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ABSTRACT
TITLE OF THESIS: Clinical, microbiological and radiographic comparison of two
treatment strategies of peri-implantitis
DEGREE DATE: June 1st 2016
NAME OF STUDENT: Genevieve Payne
B.A., COLLEGE/UNIVERSITY: Health Sciences at De Maisonneuve College, Canada
D.M.D. UNIVERSITY: University of Montreal, Canada
Directed by: Dr. Saynur Vardar-Sengul, Department of Periodontontology, Nova
Southeastern University
Dental implants have revolutionized the world of dentistry since their discovery by
Branemark (5). Millions of dental implants are being placed in the United States every
year. Dental implants are the best option for many people to replace missing teeth in a
predictable fashion. In spite of the high success and survival rates of dental implants,
complications and failures can occur. Peri-implantitis generates an inflammatory
response that involves both soft tissue inflammation and progressive loss of supporting
bone beyond biologic remodelling (AAP consensus paper 2013 (2)).
A recent meta-analysis by Decks in 2016 (13) reported the prevalence of peri-implantitis
to be 45% in patients. The statistical analyses suggest that hundreds of thousands of
implants are affected by peri-implantitis. The increasing number of implants placed
increases the need for treatment of implants affected by peri-implantitis. The cost of
losing an implant due to peri-implantitis is tremendous financially and emotionally for
6

the patient. The progression rate of peri-implantitis is very fast; therefore, early detection
and early treatment is crucial. Current treatment strategies report about 50% success rate
(Froum, Froum and Rosen 2015 (43)). In 2009, Romanos, Froum and Tarnow (56)
presented a surgical protocol for implant surface decontamination using the CO2 laser and
found the results to be promising.
Therefore, the purpose of this study is i) to evaluate the effect of CO2 laser in
combination with hydrogen peroxide in the treatment of peri-implantitis lesions in
humans and ii) to compare clinically, microbiologically and radiographically the effects
of this new treatment to the conventional approach. Our study design innovatively targets
decontamination of the implant surface for regeneration and also potentially may create a
surface that could allow for re-osseointegration. This approach is new in the field of
implant dentistry.
A total of ten (n= 10) patients, who were diagnosed with peri-implantitis after one year of
implant loading were selected. They were randomly divided into two groups: Test Group
(n=5) and Control Group (n=5). The test Group underwent a new proposed protocol,
which consists of using CO2 laser in combination with H2O2 along with citric acid
decontamination and bone grafting. The Control Group underwent a similar treatment
without the use of the CO2 laser in combination with H2O2. One week, 1 month, 3 months
and 6 months post-operative appointments followed to compare clinical, radiographic and
microbiological outcomes of each group.
Before we proceeded, we tested the laser on expired implants to insure the CO2 laser was
safe to use at the recommended settings. The SEM was used at 250 X and 38X
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magnifications and it was concluded that we could proceed with our protocol since the
surface was unaffected.
The microbiologic samples were analyzed at the OMTS Laboratory at the Kornberg
School of Dentistry of Temple University, Pennsylvania. The radiographic bone fill were
compare using the standard radiographs with periapical and bitewings registrations in
PVS. The resulting digitized images of the radiographs were analyzed using the
measurement options of the computer software of the XDR program. A computerassisted calibration was carried out for each implant. For each implant, the distance
between the implant shoulder, which was the chosen landmark, and the most coronal
aspect of the alveolar crest at mesial (M) and distal aspects (D) was measured separately.
Bone loss or bone gain was calculated by comparing measurements made with the
radiographs from the baseline of the study and from the 6 months post-operative
radiographs. The clinical measurements included: probing depth (PD), clinical
attachment levels (CAL), plaque score (PI), bleeding score (mBoP), keratinized gingiva
(KG), mucosal recession and were examined by 2 operators for better standardization.
The clinical measurements were analyzed using pairwise comparisons with a Bonferroni
adjustment.
The analysis revealed interesting results. It can be concluded that:
1. Smokers had a statistically significant less bone fill after the six-months post-op
appointment (P = 0.042). Smokers had 2.40 times lower levels of bone fill compare to
non-smokers. Furthermore, the smokers had residual probing depth of ≥ 6mm and only
13% of the non-smokers had ≥ 6mm probing depth. Thus, tobacco consumption seems to
have a negative impact on healing and regenerative outcomes and smoking is a risk factor
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for peri-implantitis.
2. All patients who smoked cigarettes were associated with a higher level of
Fusobacterium Nucleatum and Parvirmonas Micra and also linked with Prevotella
Intermedia and Tannerella forsythia. One patient also had Enteric Gram-Negative rods.
The non-smokers had a more diverse microbiome consisting of Streptococcus
constellatus, Campylobacter rectus, Staphylococcus aureus, Tannerella forsythia,
Fusobacterium Nucleatum, Parvirmonas Micra and Prevotella Intermedia.

3. Most of the bacteria harboured around the implants affected by peri-implantitis were
from the orange complex and included: Campylobacter rectus Fusobacterium Nucleatum,
Parvirmonas Micra and Prevotella Intermedia. Removal of plaque and bacteria is
imperative in order to have peri-implant health.

4. Plaque was statistically positively correlated to the prosthesis type (P < 0.001),
meaning there was more plaque with hybrid prosthesis than with a single unit crown on
implant. The flanges on the buccal of the prosthesis make the flossing and the brushing
around the implants difficult. Hybrid prostheses have a higher prevalence of periimplantitis.

5. Clinical, microbiological and radiographic improvements were noted in both groups
post-operatively. The test group showed a tendency for higher increase in clinical
attachment level gain and decrease in probing depth while not increasing recession. Both
groups showed better BOP scores after treatment.
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6. Radiographic bone fill wasn’t successful in all patients. Some patients were refractory
to the surgical procedure. These patients had similar characteristics including smoking
tobacco, presence of Enteric gram negative rods and 50% of bone loss pre-operatively.
7. The treatment of peri-implantitis must include a surgical procedure. It is necessary for
the proper access to the implant and visualization of the defect to open a flap.
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GLOSSARY OF STATISTICAL TERMS

P value: The probability of obtaining a result as extreme as the one that was actually
observed from chance alone. The P value significance level used in this research was P
<0.05.

Kendall’s rank correlation: This test is a non-parametric test to measure the ordinal
association between two measured quantities.

Bonferroni adjustment: The Bonferroni correction is an adjustment made to P values
when several dependent or independent statistical tests are being performed
simultaneously on a single data set.

Pairwise comparison: Test to know which groups are significantly different from which
other group. The most obvious approach is the t-test.

T-test: This tests if the sum of the change between two groups differs statistically from
zero. Commonly applied when the test statistic would follow a normal distribution.
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1. INTRODUCTION

1.1 History of dental implants
Dental implants have a fascinating history that starts earlier that we can believe. Humans
have always tried to replace missing teeth with various materials. The first evidence of
dental implants was recognized at around 600 of the Common Era. The Mayans were
utilizing pieces of shells as implants as a substitute for mandibular teeth. Radiographs
taken in the 1970’s of their mandibles showed compact bone formation around the
implants-bone interface. Furthermore, an implant made of stone was found in Hondurans’
mandibles in 800 CE (5). Several dental practitioners were involved in the development
of the dental implant. Dr. Leonard Linkow made variations to the blade implant and
developed the Ventplant implant that could be placed in both mandible and maxilla (the
blade implant is now accepted to be an endosseous implant category). Further on, Dr.
Small developed the first transosteal implant called the mandibular staple implant to help
patients with extremely atrophic edentulous mandible. In 1978, Dr. P. Brånemark
presented a two-stage threaded titanium root-form implant, which he designated as
“fixtures”(4). He discovered this accidentally in 1952 when he was studying blood flow
in rabbit femurs by placing titanium chambers in their bone; over time the chamber
became firmly fixed to the bone and could not be removed. He was originally placing
implants in patients who had severe deformities of the jaw and chin as well as
congenitally missing teeth and misaligned teeth. One of his first cases was a patient
requiring 4 implants in the mandible. The ladders were restored after 6 months and stayed
in place for the next 40 years (up to 2006) (4). His experiments were the first to be
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published in 1965 and also his implants placed in humans were the first to be well
maintained in the oral cavity (4).
Dental implants are surgically inserted in the bone of patients and will eventually
integrate in their bodies with the concept of osseointegration. Osseointegration implies a
firm, direct and lasting connection between vital bone and screwed implants without a
soft tissue interposition (6). It can support a dental prosthesis such as a crown, bridge,
denture, facial prosthesis or to act as an orthodontic anchor (7). The success or failure of
osseointegation depends on numerous factors including the health of the patient, the
surgical protocol, smoking habits, intake of bisphosphonates and habits such as bruxism.
(8). The complications and risks of dental implants include the ones that occur
immediately during surgery such as excessive bleeding or nerve injury (9). Infections and
failures usually strike in the first 6 months and would be considered delayed
complications (10). Mechanical overload failures and peri-implantitis occur over months
and years (2). On the stipulation that an implant is placed ideally, that it osseointegrates
and a proper prosthesis is fixed, dental implants conferred multiple advantages. These
advantages include improvement of esthetics, improvement of speech, improve comfort,
better mastication and improve self-esteem and general oral health (11, 12, 13, 14).

1.2 Anatomy of the mucosa around dental implants
Peri-implant mucosa is the term used to identify the soft tissue around dental implants.
This soft tissue attachment provides a barrier against pathogens and other debris from the
oral cavity. This allows a seal and insures osseointegration of the implant after its
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placement. Although teeth and implants have several similarities, they are very different
for numerous reasons. Around both implants and natural teeth, the oral epithelium is
keratinized and continuous with the junctional epithelium. The article from Berglungh
(3) 1994 on peri-implant mucosa was frequently cited. It says that the junctional
epithelium and the sulcus of the implant are seen as one structure that we call the barrier
epithelium. The distance of the ladder varies between 1.8mm and 2.2mm. The connective
tissue is the layer starting from the apical extend of the barrier epithelium and goes up to
the crest of the bone and is usually 1.5mm to 2.0mm. The blood vessels of the periimplant mucosa are terminal branches of larger vessels originating from the periosteum
of the bone of the implant site. These supra-periosteal vessels give off branches to the
supra-alveolar mucosa and formed the capillaries underneath the oral epithelium and the
vascular plexus located directly lateral to the barrier epithelium. The connective tissue
that is part of the transmucosal attachment to titanium implants contained only few
vessels, all of which could be identified as terminal branches of the supra-periosteal
blood vessels. (3)
As oppose to the teeth, a periodontal ligament does not surround the implants since there
is no cementum like in teeth. The collagen fibers adjacent to the implants originate from
the bony crest and are oriented parallel to the implant surface. The connective tissue
supra-crestally comprises fewer fibroblasts and vascular structures but more collagen
fibers than the tissue in the equivalent location at teeth. (15, 16)
These observations show that the mucogingival complex surrounding implants have a
lack of vascularization and therefore the implant tissues may have a decreased defense
system. This may, in part, explain the more extensive progress of bone loss with plaque23

associated inflammation that occurs in dental implants. (3)

1.3 Definition of peri-implantitis
Peri-implant diseases present in two forms: peri-implant mucositis and peri-implantitis.
Peri-implant mucositis is an inflammatory response limited to the soft tissues surrounding
a functioning dental implant, with no signs of loss of supporting bone following initial
bone remodelling during healing. According to the American Academy of
Periodontology, peri-implantitis generates an inflammatory response that involves both
soft tissue inflammation and progressive loss of supporting bone beyond biologic
remodelling (2013(2)).

1.4 Classification of peri-implantitis
Several classifications exist in order to characterize the amount of bone loss around an
implant. Grading systems use in epidemiological studies have been proposed but have not
been applied consistently. Some studies classify the extend of severity with clinical
probing depth and gingival inflammation (Zitmann 2008, 18), others with radiographic
bone loss and gingival inflammation and some include both the Probing depth (PD) value
and radiographic bone loss as well the gingival inflammation present (1). There is also a
classification by Sarmiento, Norton and Fiorellini (19) based on the etiology of the bone
loss around implants: biofilm or bacteria-induced, bone loss related to exogenous irritants
such as dental cement, related to iatrogenic factors such as thinning out the buccal plate
or placing an implant too buccally, bone loss related to extrinsic pathology such as apical
periodontal lesions of adjacent and lastly, peri-implantitis related to an absence of
24

keratinized tissue with mobile mucosa and/or muscle attachments. Roos-Jansaker,
Renvert and Egelberg

(2003) (25) described peri-implantitis of marginal bone loss

greater than 3 mm, bleeding on probing (BOP) and/or purulence.
The classification used in this research study is the one from Froum and Rosen (1)
published in 2012. Early peri-implantitis would be defined as a PD ≥ 4 mm with bleeding
and/or suppuration on probing as well as bone loss up to 25 % of the implant length. A
moderate peri-implantitis would be defined as a PD ≥ 6 mm with bleeding and/or
suppuration on probing as well as bone loss up to 50 % of the implant length. A severe
peri-implantitits would be defined as a PD ≥ 8 mm with bleeding and/or suppuration on
probing as well as more than 50% of bone loss of the implant length. The bleeding on
probing and/or the suppuration around the implant have to be noted on two or more sites
of the implant. The bone loss has to be measured on radiographs from the time of
insertion of the definitive prosthesis to the current radiograph. If not available, the earliest
available radiographs following loading should be used.

1.5 Prevalence of peri-implantitis
Three million Americans have dental implants to replace five million missing teeth each
year (20). The increasing number of implants placed increases the need for treatment of
implants affected by peri-implantitis. Discrepancies in study design, in the duration of the
post-operative appointments, in the implant systems used are also an integral limitation
that needs to be acknowledged, as does the lack of standardization in reporting outcomes
at both participant and implant levels. The prevalence will fluctuate depending on the
bone loss threshold and/or probing depth threshold used for the definition. A meta25

analysis by Momen et al. 2013 (21) included 9 papers with an observation period that
ranged from 5 years to 10 years. All of the studies presented data on the frequency of
peri-implantitis. They reported the prevalence of peri-implantitis to be 18.8% in patients
and 9.6% at the implant level. They mentioned that the frequency could increase up to
36.3% amongst smokers and up to 21.1% in patients with previous history of
periodontitis. It could decrease to 14.3% if the patient is involved in rigorous
maintenance programs. A study by Simonis in 2010 (22) evaluated 131 implants placed
over 10 to 16 years. The peri-implantitis rate was 23.53% for smokers and 16.51% for
non-smokers at the implant level. A study by Koldsland (23) published in 2010 analyzed
351 implants with a mean functional loading time of 7.4 years and 99 subjects were
available for analysis. They found a total of 20.4% of the subject population having periimplantitis and 11.4% of the implants. In 2006, Roos-Jansaker and Renvert (24)
published an article on peri-implant lesions on implants after 9 to 14 years in function. It
was estimated that 6.6% of the implants and 16% of the patients were diagnosed as
having peri-implantitis. Fransson, Lekholm and Berglundh published on the prevalence
of peri-implantitis in 2005 (26). The prevalence of implants with progressive bone loss
(pass the 3rd thread (>2mm)) was 12.4% at the implant level, whereas on the subject level
it was more than twice as high (27.8%). Fardal (2013) (29) did a study on 143 patients
who were previously treated for periodontitis and got implants afterwards. They were all
involved in a maintenance program. At the 7 years follow-up, the prevalence of periimplantitis was 53.5% at the patient level and 31.1% at the implant level suggesting that
previous periodontitis history can be an important risk factor for peri-implantitis.
More recently in 2016, Derks and al. published an article in the Journal of Dental
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research on the prevalence of peri-implantitis (27). Out of the 427 patients with baseline
radiographs, 192 (45.0%) had peri-implantitis. Furthermore, 62 patients, which means
14.5% of the patients, had moderate to severe peri-implantitis.

1.6 Etiology of peri-implantitis
Oral hygiene: Immediately after their placement, implants will start collecting bacteria
(30). This will continue to occur over time with the presence of plaque. Dental plaque
accumulation is associated to poor oral hygiene; therefore poor oral hygiene will be
correlated to bone loss around implants. Ferreira et al. 2006 reported an odd ratio for
development of peri-implant diseases of 14.3 with very poor oral hygiene and bleeding
on probing of 30% and more (31). He linked peri-implantitis directly to plaque
accumulation and stated that it was one of the main etiologies. In a meta-analysis, HeitzMayfield also linked poor oral hygiene to peri-implantitis (58). Furthermore, Lindquist et
al. (32) established that patients who were smokers and had a bad oral hygiene were three
times more prone to develop peri-implantitis after 10 years compared to non-smokers.
Microbial biofilm composition: Several studies have evaluated the microbiota around
implants affected by peri-implantitis. The composition of microorganisms is similar to
the mixed anaerobic composition of teeth with chronic periodontitis. Nonetheless, some
studies have identify microorganisms that cannot be found routinely in periodontal
pockets, which are Staphylococcus aureus, Enerobacteriaceae, Candida albicans, and
Pseudomonas aeruginosa (Salvi et al. 2008, (33)). Staphylococci especially have a high
affinity for titanium surfaces. In 2007, Renvert used DNA-DNA hybridization to
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analyzed 40 species around implants and concluded that there were higher counts of
Eikenella corrodens, F. nucleatum sp. vincentii, P. gingivalis, and Parvimonas micra in
deeper peri-implant pockets (34). Numerous studies have established that the
microorganisms level is higher in peri-implantitits compare to healthy implants (35, 36,
37, 38). The peri-implant pocket represents a niche for those bacteria to accumulate, to
replicate and to participate in the development of peri-implant infections.
Microbiota at implants in fully and partially edentulous patients: Studies involving
the fully and partially edentulous patients and very conflicting. Nonetheless, the majority
of papers established that there is an increase in the bacterial levels in partially edentulous
patients. Teeth could therefore increase the harboring plaque on implants and contribute
to peri-implantitis. (36, 39, 40)
Excess cement: Cementation of a crown is an alternative option to a screwed retained
prosthesis. It is often used in the anterior when an implant is buccally placed. In spite of
careful clinical control, cement is frequently found in excess along the gingival margin
and even more if the implant is deeply placed. The cement acts as a foreign body and
accelerates the accumulation of microorganisms resulting in the development of periimplantitis. Wilson (2009) (41) found excess cement in 81% of peri-implantitis cases and
after the removal of the cement; peri-implant diseases were absent in 74% of cases. As of
Linkevicius (2013) (42), he found 85% of peri-implantitis cases associated to excess
cement and also mentioned that dental radiographs were not considered an appropriate
tool to detect excess cement around dental implants (43).
History of periodontitis: Karroussis et al. have concluded that patients with a previous
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history of periodontitis presented over time a more important probing depth, more
marginal bone loss and a higher incidence of peri-implantitis when compared with patient
with healthy periodontium (44). Other studies have also established the link between
marginal bone loss, peri-implant diseases and previous periodontal treatments (31, 45).
Genotyping: Peri-implantitis mainly originated by bacteria but is host mediated like
periodontitis (46). The tissue breakdown is caused by an overproduction of proinflammatory cytokines. An increase in tissue destruction may be generate in the case of
an individual who is genetically predisposed to overproduce pro-inflammatory cytokines,
such as interleukin 1b (IL- 1b), interleukin 6 (IL-6), interleukin 17 (IL- 17), or tumor
necrosis factor a (TNF-a) (47).
Smoking: Nicotine decreases the available blood supply in the gingiva and the bone
surrounding dental implants and therefore could impair bone healing (48). Roos-Jansker
et al., Pesce et al. and Swierkot et al. have identify a clear relationship between smokers
and peri-implantitis as well as implant failure (49, 50, 51). This could be due to elevated
total white blood cell and granulocyte counts, PMN viability and hydrogen peroxide
generation. Numerous articles demonstrated a clear association between the negative
effect of cigarettes and peri-implant mucositis and peri-implantitis (52, 52, 54, 55).
Maintenance therapy: Peri-implantitis can be developed in patients without a structural
maintenance program compare to patients that comply with regular maintenance
appointments (Odd ratio of 5.92) (56). According to Meyle 2014, patients attending
regular maintenance appointments demonstrated stable clinical and radiographic bone
level and peri-implant gingival health over a period of 10 years (57). In a study by Chung
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et al. 2006 (63), periodontal maintenance was even more important in the situation where
implants had less than 2 mm of keratinized gingiva or less than 1mm of attached mucosa.
Systemic diseases: On the premise that systemic diseases can influence the development
of periodontitis, one could conclude that it there is a similar risk with peri-implantitis.
Nevertheless, Heitz-Mayfield (58) originally underlined that there is limited evidence
between systemic diseases and peri-implantitis. However, in a recent retrospective study,
Renvert et al. 2014 (59) concluded that patients with cardiovascular diseases have an odd
ratio of 8.7 of developing peri-implantitis. Another study by Daubert (2015) (60)
concluded that patients with diabetes were more prone to develop peri-implantitis. In a
study by Ferreira et al. (31), they recorded glycemic data at the time of implant surgery.
They requested a medical evaluation for all subjects diagnosed with diabetics at the time
of surgery as well as for those who stated having the disease at the time of evaluation.
Diabetes mellitus was diagnosed if an individual had fasting blood sugar 126 mg/dl or
had been taking anti-diabetic medicine over the past 2 weeks. In their study, they
observed that subjects with diabetes were more frequently diagnosed with peri-implant
diseases.
Keratinized gingiva: Bouri and Bissada 2008 (61) and Lin et al. 2013 (62) showed
similar results where implants supported by 2mm of keratinized gingiva were associated
with less marginal bone loss and less peri-implant inflammation. An article published by
Chung, Misch and Wang in 2006 (63) discussed the importance of keratinized gingiva/
attached mucosa around implants. They evaluated a total of 69 implants. Their results
indicated that there was no statistical difference between bone loss around implants with
<2mm or >2mm of keratinized gingiva or with <1mm or >1mm of attached mucosa.
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Although they didn’t find any difference in the amount of bone loss in regards to the
keratinized tissues they found that a presence of adequate keratinized gingiva of 2 mm or
more shown to be significantly advantageous in the reduction of gingival inflammation
and plaque accumulation. The gingival index and the plaque index were statistically
significantly higher in the group of 2mm or less of keratinized gingiva (0.94 and 1.51)
and the group with less than 1 mm of attached mucosa (0.95 and 1.50) than in the group
with 2mm or more of keratinized gingiva (0.76 and 1.26) and the group with more than
1mm of attached mucosa (0.70 and 1.19), respectively.
Biomechanical overload: Occlusion as a risk factor for peri-implantitis remains
controversial. The mechanical stress that overload can cause has been hypothesize to
possibly produce deformation of the bone at the implant-bone interface. Some studies
mentioned that it could create a possible implant loosening and a fibrous tissue
connective tissue (Renvert 2015) (64). Mechanic stress has also been suggested to be a
co-factor in the initiation and also the progression of peri-implantitis (65). In a study on
4 monkeys, Miyata et al. 2000 (66) found significant bone resorption observed around the
implants that had both peri-implant inflammation and an excess occlusal overload of 100
μm applied for a four week period. They also mentioned that an occlusal overload of 180
μm without peri-implant inflammation could also play a role in the bone breakdown
around implants. On the contrary, a study by Heitz-Mayfield et al. in 2004 (67) was
performed on Labrador dogs and they concluded that, in the presence of peri-implant
mucosal health, excessive occlusal load did not result in loss of osseointegration or in
bone loss when compared with non- loaded implants. Nonetheless, no force
measurements were implemented in this study.
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1.7 Current strategies of peri-implantitis
The etiopathogenesis of peri-implantitis not well understood and is certainly
multifactorial. Therefore, the most effective and predictable treatment for peri-implantitis
has not yet been identified. Various modalities to treat infected implant surfaces have
been suggested. Some of them include mechanical debridement, antiseptic and airabrasive treatment, photodynamic treatment, laser application, and surgical regeneration
(68, 70, 71). Current treatment strategies report about 50% success rate (Froum, Froum
and Rosen 2012 (68)).
Non-surgical: Leonardt and Renvert 2003 (70) suggested treating peri-implantitis with
non-surgical therapy consisting of the complete removal of granulomatous tissue, the
irrigation of the implant with hydrogen peroxide and saline, the sterilization of the
abutment, the irrigation of the implant with chlorhexidine and the prescription of
systemic antibiotics to the patient. They had recalls every 3-6 months for 5 years. A total
of 26 implants were treated: 4 continued to lose bone, 7 implants were lost, 9 implants
showed unchanged bone levels and finally 6 gained bone (70). They later published (25)
an article stating that although nonsurgical treatments are recommended for peri-implant
mucositis lesions, their use has been proven not to be effective in peri-implantitis lesions.
Non surgical and Surgical: The cumulative supportive therapy (CIST) has been
suggested by Lang in 2004 to treat peri-implantitis (71). It consists of treating the implant
according to the radiographic bone loss, the peri-implant probing depths and the presence
or not of bleeding and suppuration on probing. The scenario A represents an implant
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probing depths of less than 3mm, bleeding on probing and no radiographic bone loss.
They suggest treating the implant with debridement and polishing. The scenario B
represents implant probing depths of less than 4 to 5mm, bleeding on probing and no
radiographic bone loss. They suggest treating the implant with debridement, polishing
and antiseptic cleansing. The scenario C represents implant probing depths of more than
5mm, bleeding on probing and less than 2mm of radiographic bone loss. They suggest
treating the implant with debridement, polishing, antiseptic cleansing and local or
systemic antibiotic therapy. The scenario D represents implant probing depths of more
than 5mm, bleeding on probing and 2mm or more of radiographic bone loss. They
suggest treating the implant with debridement, polishing, antiseptic cleansing, local or
systemic antibiotic therapy as well as a regenerative or resective therapy.
Surgical: The group of Hom-Lay Wang published in 2014 on the guidelines of periimplantitis treatments (72). They first explained the importance of measuring all the
clinical parameters and evaluating radiographs in order to treat the patient properly, every
parameter will guide the clinicians in their treatment. They state that the only parameter
that would dictate immediate removal of the implant is the clinical presence of mobility.
When the value of probing depth is 5mm or more and there is 2mm or more of
radiographic bone loss, open flap is recommended. After flap elevation, they recommend
removing all granulation tissue and decontaminating the implant surface either with
mechanical or chemical disinfectants. In the case of circumferential bone defects, they
recommend grafting procedures and in cases of irregular bone defects, they recommend
bone recontouring. In the case where the prosthesis needs to be remove for the healing
period (the crest of the bone is near the implant shoulder), they recommend waiting a
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period of 6 months before placing the new prosthesis to ensure proper integration of the
graft. When the implant has lost more than 50% of the radiographic implant length, they
recommend the removal of the implant followed by guided bone regeneration. In all
treatment, if there is a lack of keratinized tissue, a soft tissue graft is recommended. The
ladder can be a free gingival graft, an allograft or a collagen membrane.
Froum, Froum and Rosen in 2012 and 2015 (68, 69) discussed the importance of the
surgical

approach

to

treat

peri-implantitis.

Their

treatment

consists

of

the

decontamination of the implant surface with the application of a Prophy –Jet, saline
irrigation, topical application of tetracycline, topical application of chlorhexidine and
more saline irrigation. This surface decontamination is followed by the application of
enamel matrix derivative or platelet-derived growth factors mixed with an anorganic
bovine bone or an allograft: Anorganic bovine bone mineral or a mineralized bone
allograft. The bone should be covered with a membrane. A connective tissue graft should
be used if there is less than 2 mm of keratinized tissue. A collagen membrane should be
used if there is sufficient keratinized tissue. They also mentioned that all patients should
be on systemic antibiotics for 7 days following the procedure (68).
Laser: Romanos and Nentwig in 2008 (73) published an article on the use of a CO2 laser
in the treatment of the implant surface prior to guided bone regeneration. They used the
CO2 laser to irradiate the exposed implant surface for 1 minute. They treated 19 implants;
they used autogenous bone on 10 implants and Bio-Oss on 9 implants. The bone was
covered with a collagen membrane. The mucoperiosteal flaps were then sutured with a 40 silk material. No systemic antibiotics were used both pre-operatively and postoperatively. After an average of 27 months, all the implants grafted with Bio-oss had
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100% of radiographic bone fill and those grafted with autogenous bone had at least twothird of radiographic bone fill. They mentioned that the laser increases the potential for
blood coagulation. They explained that the clot insure the stabilization of the graft which
is necessary for re-osseointegration.

1.8 Disinfection of implants
Disinfecting the implant surface is the key to be able to have a successful regeneration
procedure. The bone particles cannot adhere to a surface where microorganisms are still
present, which is the same concept as periodontal regeneration on natural teeth. Different
methods exist to decrease the bacterial load but none are efficient to sterilize the implant
surface. Gosau et al. (74) discussed about different antimicrobials agents used to detoxify
titanium disks: hypochlorite, hydrogen peroxide, citric acid, chlorhexidine, Listerine, and
Plax. All tested antiseptics seem to be able to reduce the total amount of microorganisms
accumulating on titanium surfaces especially hypochlorite, hydrogen peroxide,
chlorhexidine and Listerine. Subramani et al. did a literature review in 2012 and
concluded that the disinfection of implant surfaces should include both mechanical and
chemical applications (75). The use of fiber carbon curettes did not show resolution of
the lesion in all cases. The use of plastic curettes did show an amount of reosseointegration along with copious saline irrigation. The use of metal curettes can
increase the bacterial colonization by altering the surface and making it rougher. As far as
chemical disinfection, they concluded that chlorhexidine and saline solutions were the
superior methods. A study compared the implant treatment with the Er: YAG laser versus
the application of cotton pellets with plastic curettes and sterile saline (76). They
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concluded that both therapies were equally efficient and there was no statistical
difference. According to recent articles, no single method of surface decontamination is
superior (77, 78).

1.9 Lasers in the treatment of peri-implantitis
Numerous articles have documented the capacity of lasers to decontaminate implant’s
surfaces by reducing the bacterial load. Romanos et al. (2003)(79) and Kato et al. (1998)
(80) confirmed a significant reduction of periodontopathogens in vitro after the use of
CO2 lasers around dental implants. In a study by Schwarz in 2005 (81), the Er;YAG (100
mJ/pulse, 10 Hz) was shown to be the best method to remove plaque and bacteria on SLA
titanium implants. Haas et al. in 1996 (82) suggested treating peri-implantitis with a dye
of toluidine blue and a photosensitization with a diode soft laser. They were able to show
with the scanning electron microscope a decontamination of titanium implants previously
contaminated with A.a, P Gingivalis and P. Intermedia. Dörtbudak et al. (82) explains
that the physical properties of the laser light and its interactions with the implant surface
(reflection, scattering, transmission, and absorption) may decontaminate the implant
threads. Several authors indicated that low- intensity lasers and high-intensity lasers are
useful for the treatment of the decontamination of the peri-implant defects (79, 80, 81,
82). However, there are no histomorphometric studies showing new bone formation and
osseointegration after the use of a laser. In an in-vitro study by Lubin et al. in 2014 (83),
they evaluated the osteoblasts attachment on previously contaminated titanium discs.
They used eighty-eight discs and contaminated them with Porphyromonas Gingivalis.
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They then used the following methods to decontaminate the discs: 24% EDTA, 12.5%
citric acid, tetracycline solution and a neodymium-doped yttrium aluminum garnet
(Nd:YAG) laser. Their results showed that the weakest method was the laser and the best
were the EDTA and tetracycline solutions.

1.10

CO2 Laser

CO2 lasers have been safely and widely used in dentistry for the past 20 years. Pick and
Colvard (1993) (84) reported their utilities in frenectomies, ablation of lesions,
gingivectomies, gingivoplasties, soft tissue tuberosity ablations, coagulation of graft door
sites and crown lengthening procedures. Around soft tissues, CO2 lasers have several
advantages over surgical procedures; minimal swelling, and scarring, coagulation,
reduction in surgical time and reduction of the post-operative pain and discomfort. Crespi
and Romanos (85) also used it as an adjunct to scaling and root planing and found
superior attachment of fibroblasts on root surfaces compare to conventional therapy.
Several studies were carried to measure the safeness of CO2 lasers around bone and
implants. In 1983, Eriksson and al. (86) demonstrated that a temperature of 47oC and over
maintained for one minute can cause irreversible damage to bone. Therefore, considering
the baseline tissue temperature at 37oC, an increase of 10oC or more during laser
application could cause irreparable damage to the bone. Geminiani and al. (2011) (87)
found an increase of temperature between 4.6oC and 5.5oC at a power setting of 2 W for
60 seconds in a pulse mode (20Hz). An in vitro study performed by Mouhyi in 1999 and
2000 (88, 89) concluded that the implant decontamination surface was successful with
the CO2 laser in combination with hydrogen peroxide and citric acid and harmless used
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on a wet implant surface in a pulsed mode at 8 W/10 ms/ 20 Hz during 5 seconds. It
provokes a temperature increase of less than 3°C. Lambrecht et al. in 2012 (90)
investigated about the mode, the suitable power for exposing implants and the time
without reaching 47 °C at the implant surface. The implants were exposed for 10 seconds
with 4, 5, 6, 7, 8, 9, and 10 W in three operating modes (continuous wave with super
pulse, continuous wave, and pulse wave) without a temperature increase of more than
+10°C taking place. After 20 seconds, there was an augmentation in the temperature
exceeding +10°C in continuous wave with super pulse, continuous wave modes above 8
W but pulsed wave mode did not produce a temperature increase exceeding +10°C. In
fact, in pulse wave mode, all the temperatures recorded were below 47°C. Romanos,
Froum and Tarnow (2009) (91) review the literature on CO2 lasers around implants
affected by peri-implantitis and conclude that the literature demonstrates enough
evidence to use the CO2 lasers to disinfect the implants prior to regeneration. Romanos et
al. (2009) (92) showed a complete bone fill radiographically after the use of CO2 lasers in
combination with a bone graft. They used CO2 lasers to irradiate the exposed implant
surfaces for a total period of 1 minute. The power setting was 2.84 ± 0.83 watts, which,
they said, not only disinfected the implant surface but also promoted blood coagulation in
the bony defect. They mentioned that it was more useful than Nd-YAG laser for the
treatment of peri-implantitis. Mouyhi et al. (2012) (93) reported that CO2 activated by
H2O2 could be an oxygen source for titanium oxide thickening on the previously diseased
implant surfaces, which could create a new surface for possible osseointegration. Their
in-vitro studies showed that this allowed a thickening on the implant surface, which
might be critical for osseointegration. Finally, implants in vivo are surrounded by mucosa
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consisting of 90% of water. Therefore, most of the heat is absorbed by the mucosa. Thus,
there is significantly less heating of implants in vivo. It was concluded “in periimplantitis treatment, the CO2 laser can be used for short exposure times and at low
irradiation power settings without causing any thermal damage to the peri-implant bone
tissue. ”

1.11

Objective of this research

There has been extensive research in order to find predictable treatment for periimplantitis. None of them show predictable regeneration, which is the ultimate goal for
peri-implantitis treatment. The purpose of this study was first to evaluate the effect of
CO2 laser in combination with hydrogen peroxide in the treatment of peri-implantitis
lesions in humans and secondly to compare clinically, microbiologically and
radiographically the effects of this new treatment to the conventional approach. This
approach is new in the field of implant dentistry.

Specifically, the goals of this study were to determine if the CO2 laser decontamination
and CO2 activated by H2O2 application can influence the implant surface, have a positive
effect on the bone fill and on the resolution of inflammation, and improve the outcome of
peri-implantitis. More specifically, to determine if this new protocol can influence the
treatment outcome measured by clinical parameters including probing depth, clinical
attachment level, bleeding on probing and plaque scores as well as radiographic
outcomes measured by standard radiographs up to 6-months after the treatment. In all
patients (5 patients in each group, total 10 patients), we aimed to compare these two

39

treatment modalities microbiologically to determine if the Test group shows better
eradication of peri-implant pathogens.
The primary goal must be to disinfect and clean the surface in order to insure its
biocompatibility, healing and even “re-osseointegration”. One of the most important
reasons for failure in the treatment of peri-implantitis is not being able to de-contaminate
the implant surface effectively since regeneration will not occur in infected surfaces
(Meyle 2012 (94)). The reasons for difficulty in decontamination includes but is not
limited to roughness of the implant surface, threaded design of the implants and difficulty
to clean it by the patient once the threads are exposed (Sanz et al. 2012 (95), Momen et
al. 2012 (96), Bassetti et al. 2013 (97). Laser decontamination followed by citric acid
application may be a better de-contamination protocol then the current protocols which
include either laser application or applications of solutions such as citric acid, tetracycline
HCl, Chlorhexidine Gluconate and H2O2. Since both approaches are attacking the
different aspects of the decontamination process, combining the two might cause a
synergistic effect. Laser kills the infected tissue and burns it while the citric acid removes
the remnants of the killed granulation tissue. De-contaminating implant surface
effectively eventually will affect the resolution if inflammation and the defect will fill
with bone around implant.
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2. MATERIALS AND METHODS

2.1 Regulatory approvals
This study was designed and performed as a double randomized clinical trial of 6 months
duration. The study protocol was submitted to and approved by the Institutional Review
Board for Research with Human Subjects (IRB) of Nova Southeastern University,
Florida, USA. (Approval: NSU IRB No. 07171416F from the Chair: Matthew Scamon,
Pharm.D., JD). The study obtains a grant from the Nova Southeastern University College
of Dental Medicine (335573).

2.2 Pilot study with the scanning electron microscopy
A pilot study was performed to analyze the effect of the CO2 laser on implant surfaces
with different settings and to obtain the best laser settings. This pilot study was essential
to insure that we were using the right settings without affecting negatively the implant
surfaces. For this purpose, we used the settings suggested by the CO2 Company – GPT
dental, Lutronic on expired implants (Nobel Tapered 6.0mm X 13.0mm). These settings
were: pulsed laser with 20ms/20Hz for 10 seconds with a cone and on a defocused mode.
We wanted to know if it would be better to use a long cone or a short cone, if we could
use it for 20 seconds and if we can use it with 30ms/30Hz. Therefore, we created 6
groups and analysed each samples with the SEM. The six groups consisted of: Group 1
had 20Hz and 200us for 10 seconds with a short cone, group 2 had 20Hz and 200us for
10 seconds with a long cone, group 3 had 20Hz and 200us for 20 seconds with a short
cone, group 4 had 30Hz and 300us for 10 seconds with a short cone, group 5 had 30Hz
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and 300um for 20 seconds with a short cone and group 6 consisted of the control group.
Groups 1 to 5 had 2 implants each and group 6 had 1 implant. During our pilot study, our
implants were carefully irrigated with saline water for 30 seconds and a delimitated
section of the implant surfaces was exposed to the CO2 laser. For the purpose of the use
of the laser, we created 6 groups. All groups were used with saline on a pulsed and
defocused mode. This test was completed before the treatment on patients. The SEM
used 38X and 250X magnification to analyzed the implant surfaces. The pilot study
revealed that all the implant surfaces were unaffected by the laser and the saline (Figures
in Results).

2.3 Patient’s selection: inclusion and exclusion criteria
Patients with peri-implantitis were enrolled to the post-graduate periodontology clinic at
the College of Dental Medicine of Nova Southeastern University.
Inclusion criteria:
1. Patients that have one or more implants diagnosed with peri-implantitis and
loaded for more than 1 year.
2. Age ≥ 18 years old
3. Absence of relevant medical conditions
4. Partially edentulous subjects with healthy or treated periodontal conditions
enrolled in a regular supportive care program
5. Early and moderate peri-implantitis defined as: (Froum & Rosen 2012 (1))
a. Early peri-implantitis: PD ≥ 4 mm (bleeding and/or suppuration on
probing) * Bone loss < 25 % of the implant length
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b. Moderate peri-implantitis: PD ≥ 6 mm (bleeding and/or suppuration on
probing) * Bone loss 25 % to 50% of the implant length**
*Noted on 2 or more aspects of the implant
** Measured on radiographs from time of definitive prosthesis loading to current
radiograph. If not available, the earliest available radiographs following loading should
be used.
6. Implant in function ≥ 1 year
7. Full-Mouth plaque Score (FMPS) ≤ 25%
8. Full-Mouth Bleeding Score (FMBS) ≤ 25%
Exclusion criteria:
1. Uncontrolled medical conditions
2. Pregnant or lactating females
3. Untreated periodontal conditions
4. Use of antibiotics for the last 3 months.
5. Subjects treated for ≥ 2 weeks with any medication known to affect soft tissue
conditions (cyclosporine, phenytoin, Coumadin, etc.)
6. Peri-implant mucositis defined as the absence of radiographic marginal bone loss
between delivery of the suprastructure and pre-screening appointment
7. Failure to sign written informed consent.

2.4 Patient sampling
Patients who developed peri-implantitis after their implant was in function for more than
1 year were included in our study. Our sample was chosen from patients affected by peri-
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implantitis who attended the Periodontology clinic of the College of Dental Medicine at
Nova Southeastern University.
We used both the implants and individuals as statistical unit in our study. As it was
difficult to recruit sufficient numbers of patients with the strict peri-implantitis criteria to
take part in a true randomized trial, we had a total 10 patients with 5 patients in each
study group (test and control groups). This study will be a pilot study to measure initial
effects and therefore there is no power analysis at this point.

2.5 Recruitment of patients
Subjects recruited were all patients at the Post-graduate Periodontology of the College of
Dental Medicine at Nova Southeastern University.
First, we worked with the director of the Periodontology department, Dr. Maria A.
Hernandez and the patient management coordinator (PMC), Ms. Gabriella Rosario to find
patients who underwent implant placement surgery in our Postgraduate Periodontology
Clinic. The patients had their restorative component in function for at least 1 year, and
now suffered from peri-implantitis. We called the patients and questioned them on their
oral health and asked them to come for a recall visit at no charge.
Second, we identified the patients who were planning a re-evaluation in the near future
with one of the residents and were present at their appointment. This allowed us to find
an appropriate sample for our study. These patients were asked if they would like to
participate in the study.
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Third, we made flyers for patients, describing briefly the research, along with the contact
information of the principle investigator. These flyers were displayed on the walls of the
Dental College of Medicine at NSU. (Appendix A)
Fourth, the principal investigator wrote a letter intended for dentists and dental specialists
working full time or part time at the Dental College of Medicine of NSU. The letter
described briefly the research, along with the contact information of the principle
investigator. These letters were delivered through email (Appendix B). Numerous
patients were evaluated to find the patients who met the inclusion criteria for the study.

2.6 Clinical evaluation
Two calibrated examiners (GP and BH) assessed the clinical parameters at six sites per
implant: disto-buccal, buccal, mesio-buccal, disto-lingual, lingual and mesio-lingual.
They were assessed at baseline, and 6 months (Only the radiographic parameters will be
assessed at baseline, 3 months and 6 months). We used the UNC probe (PCP15; HuFriedy, Chicago, IL, USA), which has marked millimeters from 1 to 15 and has been
used in numerous studies. The implant shoulder was used as landmark for the clinical
attachment level and for the mucosal recession. The clinical measurements were as
follow:
o Probing depth (PD): in millimeters
o Clinical attachment level (CAL): in millimeters
o Mucosal recession: in millimeters
o Keratinized gingival width: in millimeters
o Modified sulcus bleeding index (mSBI): (Mombelli et al. 1987 (98))
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Score 0: No bleeding when a periodontal probe is passed along the mucosal
margin adjacent to the implant.
Score 1: Isolated bleeding spots visible.
Score 2: Blood forms a confluent red line on margin.
Score 3: Heavy or profuse bleeding.
o Inflammation: based on the gingival index (GI): (Loe 1967 (99))
GI 0= Normal gingiva: pink, matte, firm
GI 1= Mild inflammation: slight color change, slight oedema, no BOP
GI 2= Moderate inflammation: redness, oedema, glazing, BOP
GI3= Severe inflammation: marked redness and oedema, ulceration, spontaneous
bleeding
o Plaque Index: based on the Modified Plaque Index (mPLI): (Mombelli et al. 1987
(98))
Score 0: No detection of plaque
Score 1: Plaque only recognized by running a probe across the surface of the
abutment.
Score 2: Plaque can be seen by the naked eye.
Score 3: Abundance of soft matter.
o Clinical mobility (M)
0: No detectable mobility
1: Clinical mobility
o Suppuration (S): within 15 seconds following pocket probing
0: No suppuration
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1: Suppuration
The examiners were blind to the measurements that the other observer obtained. The
calibrated periodontal probe was used to measure probing depths, clinical attachment
levels, to determine the width of attached gingiva and to assess for the presence of
bleeding and/or purulent exudate (pus). Thus, it can be predicted that a manual
attachment level measurement will be subject to a measurement error usually equal to or
greater than the error of the probing depth measurement alone. The combined error for a
single attachment level measurement was reported to range between ± 0.40 mm and ±
0.90 mm (Glavind and Loe, 1967 (100); Badersten et al., 1984 (101)).

Therefore, all clinical parameters that were measured included probing depth, clinical
attachment levels, plaque score, bleeding score, keratinized gingiva width, mucosal
recession. The implant types, the loading period of the implants, and restoration types
were also recorded.
2.7 Radiographic evaluation
Standard radiographs with periapical and bitewings registrations in PVS were used. It
was shown that bite registration on individual bite blocks is enough to obtain identical
parallel periapical and bitewings radiographs (Khojastepour, L et al. (102)). Subtraction
radiography allows to digitally compare periapical radiographs from different time points
to obtain information on the bone loss and slight variations in bone density that would be
more challenging to detect with conventional radiographic analysis (103).
The resulting digitized images of the radiographs were analyzed using the measurement
options of the computer software of the XDR program. The inter-thread pitch distance
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reported by the manufacturer or the length of each implant was used for the calibration of
the apical-coronal measurements in each radiograph. A computer- assisted calibration
was carried out for each implant by evaluating the implant length as a reference. For each
implant, the distance between the implant shoulder, which was the chosen landmark, and
the most coronal aspect of the alveolar crest at mesial (M) and distal aspects (D) was
measured separately. Bone loss or bone gain was calculated by comparing measurements
made with the radiographs from the baseline of the study and from the 6 months postoperative radiographs. The radiographic changes were compared within groups and
between groups.

2.8 Microbiologic evaluation
Microbiological testing was done on the implant sites presenting with the deepest probing
depths at baseline. Samples were taking at baseline and at 6 months at the same sites. The
sites were isolated with cotton rolls and submucosal plaque samples were collected using
fine sterile paper points. The paper points were inserted at the depth of peri-implant sites
and left for 15 seconds. The paper points were transferred to a vial and sent to a
microbiological laboratory where they were analyzed. The microbiological culturing was
done at the OMTS Laboratory at the Kornberg School of Dentistry of Temple University,
Pennsylvania. We used this laboratory because the OMTS Laboratory is the only
nationally-based diagnostic periodontal microbiology testing center in the United States
to routinely carry out antibiotic resistance testing on clinical isolates of periodontal and
peri-implant bacterial pathogens (Clinical Laboratory Permit No. 021872). The pooled
subgingival plaque samples were transported for processing within 24 hours via
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overnight delivery services at the OMTS. Upon arrival at the OMTS Laboratory, the
o

vials were first warmed to 35 C for 10 minutes prior to processing in order to liquefy the
gelatin. The sampled plaque organisms were then mechanically dispersed in the medium
with a Vortex mixer at the maximal setting for 45 seconds. Serial 10-fold dilution of the
dispersed bacteria were carried out in Moller’s anaerobic dispersion solution, comprised
of pre- reduced anaerobically sterilized 0.25% tryptose -0.25% thiotone E peptone- 0.5%
NaCl. Using a sterile bent glass rod, 0.1ml aliquots of appropriate dilutions were plated
onto pre-reduced enriched Brucella blood agar (EBBA), comprised of 4.3% Brucella
agar, supplemented with 0.3% bacto-agar, 5% defibrinated sheep blood, 0.2% hemolyzed
sheep red blood cells, 0.0005% hemin and 0.00005% menadione. EBBA plates
o

inoculated with 10-4 to 10-5 specimen dilutions and incubated at 35 C for 7 days in a Coy
anaerobic chamber containing 85% N2-10% H2 – 5% CO2 were used to determined total
anaerobic viable counts, and presumptive identification of of P. Gingivalis and various
other bacterial species implicated in the etiology of peri-implantitis. Proportional subjects
recovery of P. Gingivalis for example, was calculated as a percent recovery of
P.Gingivalis colony forming units (CFU) among the total subgingival anaerobic viable
count on non-antibiotic supplement EBBA plates. All microbiological analysis were
analyzed by a laboratory technician and then reviewed by the laboratory director (Dr.
Thomas E. Rams). Antibiotic resistance screening was performed by supplementing
additional enriched Brucella blood agar plates with therapeutic concentrations of either
doxycycline, clindamycin, amoxicillin or metronidazole, using United States Clinical
Laboratory Standard Institute (CLSI) non-susceptible breakpoint concentrations for
antimicrobial susceptibility testing of anaerobic bacteria: 4µ/ml for clindamycin
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(susceptible concentration = 2µ/ml or less), 8µ/ml for amoxicillin (susceptible
concentration = 4µ/ml or less), and 16µ/ml for metronidazole (susceptible concentration
= 8µ/ml or less) (National Committee for Clinical Laboratory Standards 2003). Absence
on the corresponding EBBA plate supplement with one of the tested antibiotics inferred a
lack of in vitro resistance to that particular antibiotic for the study subject, and indicated
that the organism was susceptible to the particular antibiotic breakpoint drug level.

2.9 Protocol for the Test group
Visit 1 – Baseline – Day 0
Subjects were asked to read and sign an Informed Consent form and were given a copy.
Medical and dental history were obtained, reviewed and kept in each study file stored in a
secured cabinet. Subjects had an oral exam to evaluate the general condition of the soft
tissue and especially the ones around the affected implant. Intraoral photos were taken.
Clinical parameters were measured including probing depth, clinical attachment levels,
plaque score, bleeding score, keratinized gingiva, mucosal recession. The implant types,
the loading period of the implants, and restoration types were noted. Microbiological
sampling was done on the implant sites presenting with the deepest probing depths at
baseline and at 6 months. Digital standard radiographs were taken at baseline, 3 months
and 6 months.

Visit 2 – Non-surgical therapy: Day 7 since baseline
One week after Visit 1, subjects came back to the Periodontics Clinic. Oral hygiene
instructions were given and importance was reinforced. Subjects were randomly assigned
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to a study group. The method chosen to randomly assign the subject was to throw a
quarter in the air and if it falls on head, the subject will be in the control group and on
tail, in the test group. Subsequently, reinforcement of oral hygiene instructions was done
and scaling and root planing was performed using titanium curettes. Subjects received a
prescription of Chlrohexidine Gluconate 0,12% were asked to use 15 ml to rinse their
mouth twice a day after meals for 30 seconds. They were asked to use it for the following
two weeks.

Visit 3 – Surgical Phase: 3-4 weeks after non-surgical treatment
Subjects were reevaluated.
If the subject had a Full-Mouth plaque Score (FMPS) of less than 25% based on the
Modified Plaque Index (mPLI - Mombelli et al. 1987) and a Full-Mouth Bleeding Score
(FMBS) of less than 25% base on the Modified sulcus bleeding index (mSBI - Mombelli
et al. 1987), he/she scheduled for the surgical phase. This phase consisted of two possible
therapy previously randomly assigned (see Visit 1): test group or control group.
The medical history was reviewed. Their blood pressure and arterial pulse were
measured. Like all surgeries at the Post-Graduate Periodontic Clinic, patients were asked
to sign a consent form for surgery and local anesthetic. The risks of the surgery including
possible damage to the vessels, to the nerves, to the adjacent structures with possible
bleeding, paresthesia, and infection were discussed. Upon acceptance and understanding,
subjects rinsed with Chlorhexidine Gluconate 0.12% prior to surgery. A topical
anesthetic was administered on the area being anesthetised. Adequate amount of
anesthetic was used and the region of the affected implant was anesthetised with the
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appropriate technique (posterior superior alveolar block, middle superior alveolar bock,
anterior superior alveolar block, greater palatin infiltration, naso-palatine infiltration,
inferior alveolar nerve block, long buccal or/and local infiltrations). Whenever possible,
implant retained dental prostheses was removed during surgery.
In the test group, a full thickness flap of the area was reflected. The area was debrided
using titanium curettes. The bacterial and inflammatory debris were vaporized with the
CO2 laser (pulsed mode with 20ms/20Hz for 10 seconds). Citric acid was applied for 30
seconds (Mouhyi et al. 2012) to detach burnt remnants from titanium surface of the
implant and all granulomatous tissue was removed. The surface of the implant was
irrigated with a saline solution for 2 minutes. H2O2 3% application as an oxygen source
was applied on the implant and was evaporated in situ with CO2 laser beam followed by a
copious saline irrigation. After, a regenerative procedure was performed whenever there
is suitable defect for regeneration (Circumferential crater type defect-4 wall defect, or 3
wall defect with buccal dehiscence) with allograft (Puros, Zimmer) and a collagen
membrane (Bio-Gide, Geistlich) was used as a membrane to cover the bone graft. The
area was closed with non-resorbable sutures (PTFE, cytoplast, Osteogenics). Postoperative instructions was given written and verbally. The subjects received a
prescription of analgesic and anti-inflammatory according to their medical conditions.
Systemic antibiotics were used according to the antibiotic sensitivity testing based on
microbiological culturing.
Follow-up appointments
Patients were seen at 1 week, 2 weeks, 1 month, 3 months and 6 months post-operatively
and surgical sites were evaluated for plaque score, redness and bleeding.
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One week after the surgery, loose sutures were removed and photos were taken. One
month after the surgery, all sutures were removed with surgical scissors and photos were
taken. At three months post-op, standard digital radiographs and photos were taken.
At the six months visit, all clinical parameters were measured including probing depth,
clinical attachment levels, plaque score, bleeding score, keratinized gingiva width and
mucosal recession. A standard digital radiograph and photos were taken.

2.10

Protocol for the Control group

For the control group, the appointments pre-surgery were the same. All parameters were
recorded as explained in the test group. The post-operative appointments were at the
same interval and consisted of the same steps as well. The surgical procedure was done as
follow: a full thickness flap of the area was reflected. The area was debrided using
titanium curettes. Citric acid was applied for 30 seconds (Mouhyi et al. 2012) to detach
burnt remnants from titanium surface of the implant and all granulomatous tissue was
removed. The surface of the implant was irrigated with a saline solution for 2 minutes.
The circumferential crater type defect-4 wall defect, or 3-wall defect with buccal
dehiscence was filled with allograft (Puros, Zimmer) and a collagen membrane (BioGide, Geistlich) was used as a membrane to cover the bone graft. The area was closed
with non-resorbable sutures (PTFE, cytoplast, Osteogenics). Systemic antibiotics were
given based on microbiological testing.

2.11

Biohazard procedures and research waste disposal

The anesthesia carpules, the needles, the blades, the gauzes, the floss, the suture needles
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used during the procedures were disposed of according to NSU standard OSHA protocols
for handling potentially bio- hazardous waste. A sterile handling technique was used
during each procedure to prevent contamination. The reference number, lot number and
expiration dates were written in the corresponding chart.

2.12

Statistical analysis and data interpretation

Once the data collection was complete by Dr. Payne and Dr. Howard, Dr. Payne entered
the data into excel statistical spreadsheets for statistical analysis.
The raw data was analyzed using pairwise comparisons with a Bonferroni adjustment to
compare statistical differences between treatment groups at the P<0.05 significance level.
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3. RESULTS

3.1 Description of the patient population
Ten patients were recruited for this clinical research. We were originally aiming for
twenty patients but our strict criteria in the school environment enabled us to get ten
patients: five in each group (Control and Test). The ten patients included one woman and
9 men; the woman was in the Control group. The mean age for the ten patients was 68.5
years old. The mean age in the Control group was 74 years old and the mean age in the
Test group was 61 years old. None of the patients in the Control group smoked and two
of the patients in the Test group did smoke (patient number 6 and 10). (Table 1)
Table 1. Description of patients’ population
Subject

Gender

Age

number

Test (T) or

Smokers (S)

Control (C)

or non-

group

smokers (NS)

1

M

57

C

N-S

2

M

80

C

N-S

3

M

86

C

N-S

4

M

68

C

N-S

5

F

79

C

N-S

6

M

67

T

S

7

M

59

T

N-S

55

8

M

59

T

N-S

9

M

66

T

N-S

10

M

56

T

S

Mean

68.5

Furthermore, in the Control Group, patient number 4 had a hybrid prosthesis and in the
Test group patient number 10 had a hybrid as well. The other patients had a single unit
crown on their implant (s). Three patients in the Control group had cemented crowns
while the prosthesis was screwed on for the other two patients. In the Test group, two
patients had cemented crowns and the three other had screwed-type prosthesis. (Table 2)
Table 2. Prosthesis type
Subject

Test (T) or

Prosthesis

Screwed (S) or

number

Control (C)

Type (Single

Cemented (C)

group

unit crown or
Hybrid)

1

C

Single unit

S

crown
2

C

Single unit

C

crown
3

C

Single unit
crown

56

C

4

C

Hybrid

S

5

C

Single unit

C

crown
6

T

Single unit

C

crown
7

T

Single unit

S

crown
8

T

Single unit

S

crown
9

T

Single unit

C

crown
10

T

Hybrid

S

Additionally, table 3 demonstrates the amount of implants treated per patients. Patient
number eight had two implants and patient number ten had originally four implants. One
of the implants, implant in position #8, was removed on the day of the surgery because of
the extensive bone loss and the mobility of the implant after the removal of the hybrid
and after raising the flap. Therefore, three implants were included in patient number ten.
Table 3. Number of implants treated per patient
Subject

Test (T) or

Number of

number

Control (C)

implants

57

group

included

1

C

1

2

C

1

3

C

1

4

C

1

5

C

1

6

T

1

7

T

1

8

T

2

9

T

1

10

T

3

Total

13

3.2 Results from the pilot study
The effects of CO2 laser on implant surfaces in different laser settings:
The titanium implants were analyzed after treatment with CO2 laser by scanning electron
microscopy at the dental medicine laboratory at Nova Southeastern University.
The six groups consisted of: Group 1 had 20Hz and 200µS for 10 seconds with a short
cone, group 2 had 20Hz and 200µS for 10 seconds with a long cone, group 3 had 20Hz
and 200µS for 20 seconds with a short cone, group 4 had 30Hz and 300µS for 10 seconds
with a short cone, group 5 had 30Hz and 300µS for 20 seconds with a short cone and
group 6 consisted of the control group. Groups 1 to 5 had 2 implants each and group 6
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had 1 implant. They were analyzed with 38 times magnification and 250 times
magnification. The images obtained by the technician showed that none of implants were
microscopically affected by the CO2 laser and all images were similar to the Control
specimen which was not treated with the CO2 laser. Figures 1-12 showed the results.
Figure 1. Scanning electron microscopy of the implant in the control group of the pilot
study at 250X magnification

Figure 2. Scanning electron microscopy of the implant in the control group of the pilot
study at 38X magnification
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Figure 3. Scanning electron microscopy of implant in the group 1 (20Hz and 200µs for
10 seconds with a short cone) of the pilot study 250X magnification

Figure 4. Scanning electron microscopy of implant in the group 1 (20Hz and 200 µS for
10 seconds with a short cone) of the pilot study 38X magnification

60

Figure 5. Scanning electron microscopy of implant in the group 2 (20Hz and 200 µs for
10 seconds with a long cone) of the pilot study 250X magnification

Figure 6. Scanning electron microscopy of implant in the group 2 (20Hz and 200 µS for
10 seconds with a long cone) of the pilot study 38X magnification
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Figure 7. Scanning electron microscopy of implant in the group 3 (20Hz and 200 µS for
20 seconds with a short cone) of the pilot study 250X magnification

Figure 8. Scanning electron microscopy of implant in the group 3 (20Hz and 200 µS for
20 seconds with a short cone) of the pilot study 38X magnification
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Figure 9. Scanning electron microscopy of implant in the group 4 (30Hz and 300 µS for
10 seconds with a short cone) of the pilot study 250X magnification

Figure 10. Scanning electron microscopy of implant in the group 4 (30Hz and 300 µS for
10 seconds with a short cone) of the pilot study 38X magnification
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Figure 11. Scanning electron microscopy of implant in the group 5 (30Hz and µS for 20
seconds with short cone) of the pilot study 250X magnification

Figure 12. Scanning electron microscopy of implant in the group 5 (30Hz and 300 µS for
20 seconds with short cone) of the pilot study 38X magnification
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We decided to use the angulated and long cones since it was easiest to manipulate in the
mouth. The groups all yieled the same results, not affecting the implant surface, we chose
group 2: 20Hz and 200µS for 10 seconds with a long cone,

3.3 Clinical measurements for test (T) and control (C) groups

3.3.1 Probing depth (PD)
Table 4. Probing depth pre-operatively and 6 months post-operatively for each implant
Subject

Test (T) or

Implant

Pre-operative

Post-operative

number

Control (C)

number

Probing Depth

Probing Depth

(mm)

(mm)

group
1

2

C

C

4

3

m-b

4

m-b

5

d-b:

6

d-b:

3

mid-b

6

mid-b

4

m-l

7

m-l

5

d-l

3

d-l

3

mid-l

3

mid-l

4

m-b

6

m-b

4

d-b:

8

d-b:

4

mid-b

6

mid-b

5

m-l

4

m-l

6

d-l

6

d-l

4

65

3

C

19

mid-l

4

mid-l

3

m-b

6

m-b

6

d-b:

5

d-b:

6

mid-b

4

mid-b

4

m-l

4

m-l

4

d-l

3

d-l

3

mid-l

2

mid-l
4

5

6

C

C

T

6

30

3

m-b

7

m-b

5

d-b:

5

d-b:

4

mid-b

6

mid-b

6

m-l

3

m-l

4

d-l

4

d-l

4

mid-l

3

mid-l

4

m-b

3

m-b

4

d-b:

5

d-b:

5

mid-b

6

mid-b

5

m-l

3

m-l

7

d-l

2

d-l

4

mid-l

4

mid-l

3

m-b

10

m-b

7

d-b:

9

d-b:

5

mid-b

10

mid-b

8

m-l

11

m-l

5

66

7

8

8

9

T

T

T

T

14

3

4

14

d-l

8

d-l

3

mid-l

7

mid-l

4

m-b

7

m-b

5

d-b:

5

d-b:

4

mid-b

5

mid-b

6

m-l

3

m-l

3

d-l

4

d-l

6

mid-l

3

mid-l

2

m-b

3

m-b

4

d-b:

3

d-b:

4

mid-b

6

mid-b

2

m-l

6

m-l

4

d-l

7

d-l

3

mid-l

5

mid-l

5

m-b

5

m-b

3

d-b:

5

d-b:

3

mid-b

3

mid-b

2

m-l

6

m-l

3

d-l

5

d-l

4

mid-l

2

mid-l

3

m-b

6

m-b

3

d-b:

8

d-b:

3

mid-b

6

mid-b

3

67

10

10

10

T

T

T

5

6

8

m-l

5

m-l

3

d-l

7

d-l

4

mid-l

5

mid-l

3

m-b

3

m-b

7

d-b:

9

d-b:

7

mid-b

9

mid-b

6

m-l

9

m-l

7

d-l

5

d-l

4

mid-l

3

mid-l

3

m-b

6

m-b

5

d-b:

2

d-b:

4

mid-b

6

mid-b

4

m-l

6

m-l

5

d-l

3

d-l

5

mid-l

3

mid-l

4

m-b

2

m-b

8

d-b:

2

d-b:

8

mid-b

8

mid-b

8

m-l

4

m-l

4

d-l

3

d-l

5

mid-l

3

mid-l

4
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The descriptive statistics for PD are found in Table 5. Results from the mixed model
showed no significant interaction between time and group (F1,152=1.41, p = 0.234)—
Figure 13. Follow-up pairwise comparisons with a Bonferroni adjustment found no
significant differences between the baseline probing depth for the test and control groups
(t143=1.80, p = 0.274). From pre-to-post, the test group showed a significant decrease in
probing depth (t76=2.93, p = 0.022, difference = 0.95, [95% CI:0.01,1.91]). In contrast,
the control group did not show a significant decrease (t76=0.80, p = 0.850). At 6-month,
no significant difference in probing depth between the groups was found (t143=0.34, p =
0.986).

Table 5. Descriptive statistics for probing depth
Group

Time

N

M

SD

30

4.67

1.52

Post

30

4.33

1.12

Pre

48

5.44

2.41

Post

48

4.48∗

1.69

ControlGroup Pre

Test Group

∗ Statistically significant difference (P=0.022)
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Figure 13. Mean line plot of changes in probing depth with 95% confidence intervals

3.3.2 Recession
Recession was minimal in both the control group and the test group pre-operatively. The
mean recession was 0.13mm and 0.83mm, respectively. The recession stayed stable in the
Test group and increased to a mean of 0.73mm in the control group.
Descriptive statistics are found in Table 6. Results from the mixed model showed a
significant interaction between time and group (F1,152=29.36, P < 0.001)—Figure 2.
Follow-up pairwise comparisons with a Bonferroni adjustment found no significant
difference between the baseline recession for the test and control groups (t116=0.42, P =
0.973). From pre-to-post, the test group showed no significant change in recession
(t76=0.00, p = 0.999). In contrast, the control group did show a significant increase (t76=6.90, P < 0.001, difference = 0.60, [95% CI:0.01,1.19]). At 6-month, a significant
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difference in recession between the groups was found (t143=5.53, P < 0.001, difference =
0.60, [95% CI:0.01,1.29]).

Table 6. Descriptive statistics for recession
Group

Time

N

M

SD

30

0.13

0.43

Post

30

0.73∗

0.94

Pre

48

0.83

0.28

Post

48

0.83

0.28

Control Group Pre

Test Group

∗ Statistically significant increase (P < 0.001)

Figure 14. Mean line plot of changes in recession with 95% confidence intervals
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3.3.3 Clinical attachment levels (CAL)
Table 7 shows the clinical attachment levels pre-operatively and 6 months postoperatively for each implant
Subject

Test (T) or

Implant

Pre-operative

Post-operative

number

Control (C)

number

CAL

CAL

(mm)

(mm)

group
1

2

3

C

C

C

4

3

19

m-b

4

m-b

5

d-b:

6

d-b:

4

mid-b

6

mid-b

4

m-l

7

m-l

5

d-l

3

d-l

4

mid-l

3

mid-l

4

m-b

6

m-b

4

d-b:

8

d-b:

4

mid-b

6

mid-b

5

m-l

4

m-l

7

d-l

6

d-l

5

mid-l

4

mid-l

4

m-b

6

m-b

7

d-b:

5

d-b:

7

mid-b

4

mid-b

4

m-l

4

m-l

5

d-l

3

d-l

4

72

mid-l
4

5

6

7

C

C

T

T

6

30

3

14

mid-l

2

m-b

7

m-b

6

d-b:

5

d-b:

5

mid-b

6

mid-b

7

m-l

3

m-l

4

d-l

4

d-l

4

mid-l

3

mid-l

4

m-b

3

m-b

4

d-b:

5

d-b:

6

mid-b

6

mid-b

5

m-l

4

m-l

9

d-l

3

d-l

7

mid-l

6

mid-l

7

m-b

10

m-b

7

d-b:

9

d-b:

5

mid-b

10

mid-b

8

m-l

11

m-l

5

d-l

8

d-l

3

mid-l

7

mid-l

4

m-b

7

m-b

5

d-b:

5

d-b:

4

mid-b

5

mid-b

6

m-l

3

m-l

3

73

8

8

9

10

T

T

T

T

3

4

14

5

d-l

4

d-l

6

mid-l

3

mid-l

2

m-b

3

m-b

4

d-b:

3

d-b:

4

mid-b

6

mid-b

2

m-l

6

m-l

4

d-l

7

d-l

3

mid-l

5

mid-l

5

m-b

5

m-b

3

d-b:

5

d-b:

3

mid-b

3

mid-b

2

m-l

6

m-l

3

d-l

5

d-l

4

mid-l

2

mid-l

3

m-b

7

m-b

3

d-b:

9

d-b:

3

mid-b

7

mid-b

4

m-l

6

m-l

3

d-l

7

d-l

4

mid-l

5

mid-l

3

m-b

3

m-b

7

d-b:

9

d-b:

7

mid-b

9

mid-b

6
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10

10

T

T

6

8

m-l

9

m-l

7

d-l

5

d-l

4

mid-l

3

mid-l

3

m-b

6

m-b

6

d-b:

2

d-b:

5

mid-b

6

mid-b

5

m-l

6

m-l

5

d-l

3

d-l

5

mid-l

3

mid-l

4

m-b

2

m-b

8

d-b:

2

d-b:

8

mid-b

8

mid-b

8

m-l

4

m-l

4

d-l

3

d-l

5

mid-l

3

mid-l

4

The descriptive statistics are found in Table 8. The mean of clinical attachment levels in
the control group were 4.80mm and 5.06mm pre- and post-operatively. In the test group,
the measurements pre- and post-operatively were 5.52mm and 4.56mm, respectively.
Results from the mixed model showed a significant interaction between time and group
(F1,152=4.85, P = 0.027)—Figure 3. Follow-up pairwise comparisons with a Bonferroni
adjustment found no significant differences between the baseline clinical attachment level
for the test and control groups (t146=1.63, P = 0.359). From pre-to-post, the test group
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showed a significant decrease in clinical attachment level (t76=2.79, P = 0.034, difference
= 0.96, [95% CI:0.01,1.91]). In contrast, the control group did not show a significant
change (t76=0.61, P = 0.928). At 6-month, no significant difference in clinical attachment
level between the groups was found (t146=1.14, P = 0.661).

Table 8. Descriptive statistics for clinical attachment level
Group

Time

N

M

SD

ControlGroup

Pre

30

4.80

1.44

Post

30

5.06

1.48

Pre

48

5.52

2.45

Post

48

4.56∗

1.68

Test Group

∗ Statistically significant decrease (P=0.034)

Figure 15. Mean line plot of changes in clinical attachment level with 95% confidence
intervals
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3.3.4 Bleeding on probing (BOP)
The bleeding on probing varied from positive bleeding to no bleeding. “N” means
negative bleeding on probing and “B” means positive bleeding on probing. Each implants
were probed at six sites (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, midlingual and disto-lingual). Each site was marked with an “N” for no bleeding and with a
“B” for bleeding on probing. In the control group, twenty-seven sites had bleeding and
three sites had no bleeding pre-operatively. At the post-operative appointment in the
control group, twenty sites had bleeding and ten had no bleeding. In the test group, fortytwo sites had presence of bleeding on probing and six sites had no bleeding preoperatively. At the post-operative appointment in the test group, twenty-nine sites had
bleeding on probing and nineteen sites had no bleeding on probing. The descriptive
statistics are found in Table X. The results from the mixed, generalized linear model,
showed a significant difference for time, but no significant interaction between time and
group c2(3, N = 156) = 9.66, P = 0.021—Figure 4. Follow-up pairwise comparisons with
a Bonferroni adjustment found no significant differences between the baseline BOP for
the test and control groups (Z76=0.32, P = 0.999). From pre-to-post, we found a
significant difference between the baseline and 6-month BOP for both groups
(Z146=2.92, P = 0.004, difference = 1.17, [95% CI:0.40,1.17]). At 6-month, no significant
difference in BOP between the groups was found (Z76=2.46, P = 0.083).

Table 9. Descriptive statistics for BOP
Baseline
Group

B

6-Months
N

B

N
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ControlGroup

27 (90.0%) 3 (10.0%) 20 (66.7%)∗

10 (33.3%)∗

Test Group

42 (87.5%) 6 (12.5%) 29 (60.4%)∗

19 (39.6%)∗

∗ Statistically significant difference compare to baseline (P= 0.004)
N: No bleeding on probing, B: Bleeding on Probing

Figure 16. Mean line plot of probability of an “0” with 95% confidence intervals

N: Probability of no bleeding on probing, B: Probability of bleeding on probing

3.4 Radiographic measurements
3.4.1

Bone loss and bone fill

Table 10 shows the bone loss measurements pre-operatively and 6 months postoperatively for each implant taken with standard periapical radiographs. Table 11 shows
the bone loss measurements pre-operatively and 6 months post-operatively for each

78

implant taken with standard bitewing radiographs. The measurements were done with the
standardized radiograph technique and with the program on XDR. The protocol is
explained in the materials and methods section.

Table 10. Bone loss measurements pre-operatively and 6 months post-operatively with
standard periapical radiographs
Subject

Test (T) or

Implant

Pre-operative

Post-operative

number

Control (C)

number

Bone loss

Bone loss

(mm)

(mm)

group
1

C

4

m-b
d-b:
Mesial

4.10

Mesial

0.66
mid-b

Distal

3.73

Distal

1.80
m-l
d-l
mid-l

2

C

3

Mesial

3

C

19

Mesial

2.27

Distal

1.56

Distal

0.71
0.43

Mesial

2.50

2.37

Distal

4.10

2.32
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Mesial
Distal

4

5

6

C

C

T

6

Mesial

5.04

Mesial

6.38

Distal

5.65

Distal

6.62

Mesial

5.95

Mesial

4.51

Distal

4.50

Distal

4.51

30

3

Mesial

7

T

14

Mesial

4.20

Distal

3.70

3.05

Mesial

3.74

1.25

80

Distal

4.04

Distal

3.08

0.74
Mesial
Distal

8

8

9

T

T

T

3

Mesial

2.92

Mesial

2.32

Distal

2.32

Distal

1.57

Mesial

3.20

Mesial

2.37

Distal

2.32

Distal

2.54

Mesial

2.51

Mesial

0.85

Distal

4.27

Distal

0.98

4

14

81

10

10

10

T

T

T

5

Mesial

4.76

Mesial

5.26

Distal

5.43

Distal

5.32

Mesial

5.18

Mesial

5.09

Distal

5.46

Distal

5.11

6

8

Mesial
Mesial

5.99

Distal

6.8

4.45
Distal
5.73

Table 11. Bone loss measurements pre-operatively and 6 months post-operatively with
standard Bitewing radiographs

Subject

Test (T) or

Implant

Pre-operative

82

Post-operative

number

Control (C)

number

group
1

C

Bone loss

Bone loss

(mm)

(mm)

4

m-b
d-b:
Mesial

4.51

Mesial

0.85
mid-b

Distal

3.84

Distal

3.07
m-l
d-l
mid-l

2

3

4

C

C

C

3

Mesial

2.44

Mesial

0.74

Distal

1.70

Distal

0.55

Mesial

3.54

Mesial

2.53

Distal

3.96

Distal

3.43

Mesial

N/A

N/A

Distal

N/A

N/A

19

6

Mesial

83

Distal

5

6

7

8

C

T

T

T

30

Mesial

5.52

Mesial

5.41

Distal

5.21

Distal

4.88

Mesial

4.07

Mesial

3.48

Distal

4.25

Distal

3.65

Mesial

4.73

Mesial

1.14

Distal

4.01

Distal

0.18

Mesial

2.75

2.19

Distal

2.61

2.37

3

14

3

84

Mesial
Distal

8

9

10

T

T

T

4

Mesial

2.62

Mesial

1.70

Distal

2.49

Distal

1.94

Mesial

2.94

Mesial

1.16

Distal

5.03

Distal

2.69

14

5

Mesial
N/A
Mesial

N/A

Distal
N/A

10

T

6

Distal

N/A

Mesial

N/A
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N/A

Distal

N/A

N/A
Mesial
Distal

10

T

8

Mesial

N/A

Mesial

N/A

Distal

N/A

Distal

N/A

Results from the mixed model showed a significant interaction between time and group
(F1,48=0.09, P < 0.922)—Figure 17. Follow-up pairwise comparisons with a Bonferroni
adjustment found no significant differences between the baseline bone loss for the test
and control groups (t31=0.31, P = 0.994). From pre-to-post, the test group showed a
significant decrease in bone loss (t24=3.14, P = 0.021, difference = 0.95, [95%
CI:0.01,1.91]). In contrast, the control group did not show a significant change (t24=2.35,
P = 0.112). At follow-up, no significant difference in bone fill between the groups was
found (t31=0.18, P = 0.997).
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Figure 17. Mean line plot of changes in bone fill with 95% confidence intervals

3.5 Microbiologic measurements of both protocols pre- and post-operatively
Using a Wilcoxon sign rank test, we found one difference in the number of bacteria pre
and post-operative appointments. Before the procedure, the bacteria present included
Campylobacter rectus, Enteric gram negative rods, Fusobacterium nucleatum, Prevotella
intermedia,

Parviromonas

micras,

Staphylococcus

intermedius,

Streptococcus

constellatus, Streptococcus intermedius, Prevotella intermedia. After the procedure, the
bacteria present included the same group of bacteria except Staphylococcus aureus,
which was absent after 6 months.

In general, the bacterial load decreased in the post-

operative laboratory results with the exception of the enteric gram-negative rods, which
increased significantly majorly due to one patient in the control group (patient number 4).
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Table 12 Descriptive table of microorganisms before and after the procedure
Pre
Microorganisms

N

Mean

SD

Median

Min

Max

A. actinomycetemcomitans

10

0.00

0.00

0.00

0.00

0.00

Campylobacter rectus

10

0.01

0.03

0.00

0.00

0.10

Candida species (yeast)

10

0.00

0.00

0.00

0.00

0.00

Enteric gram negative rods

10

0.60

1.90

0.00

0.00

6.00

Enterococcus faecalis

10

0.00

0.00

0.00

0.00

0.00

Fusobacterium nucleatum

10

7.59

6.83

4.55

0.00

19.10

Parvimonas micra (micros)

10

5.30

2.31

4.40

2.00

8.60

Porphyromonas gingivalis

10

0.00

0.00

0.00

0.00

0.00

Prevotella intermedia group

10

1.50

1.76

0.95

0.00

4.60

Staphylococcus aureus

10

0.40

1.26

0.00

0.00

4.00

Streptococcus constellatus

10

0.57

1.32

0.00

0.00

4.00

Streptococcus intermedius

10

0.00

0.00

0.00

0.00

0.00

Tannerella forsythia

10

0.79

1.49

0.00

0.00

4.40

Post
Microorganisms

N

Mean

SD

Median

Min

Max

A. actinomycetemcomitans

10

0.00

0.00

0.00

0.00

0.00

Campylobacter rectus

10

0.01

0.03

0.00

0.00

0.10

Candida species (yeast)

10

0.00

0.00

0.00

0.00

0.00

Enteric gram negative rods

10

8.87

27.3

0.00

0.00

86.70
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5
Enterococcus faecalis

10

0.00

0.00

0.00

0.00

0.00

Fusobacterium nucleatum

10

1.67

2.27

0.40

0.00

6.40

Parvimonas micra (micros)

10

3.38

4.23

1.85

0.00

12.00

Porphyromonas gingivalis

10

0.00

0.00

0.00

0.00

0.00

Prevotella intermedia group

10

2.96

3.44

2.00

0.00

8.90

Staphylococcus aureus

10

0.00

0.00

0.00

0.00

0.00

Streptococcus constellatus

10

0.80

2.53

0.00

0.00

8.00

Streptococcus intermedius

10

0.13

0.41

0.00

0.00

1.30

Tannerella forsythia

10

0.08

0.25

0.00

0.00

0.80

Figure 18. Mean line plot of change in number of bacteria pre-to-post
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In the Wilcoxon sign-rank test, we calculate the Z-score. The z-score tells us if the results
was obtain by chance or is likely to have occurred expectedly. The bigger the value of the
Z-score is, whether is positive or negative, the less likely it has occurred accidently.
Therefore, this test indicates that some bacteria are more expected to be present around
dental implants with peri-implantitis. These bacteria include: Candida species,
Enteroccoccus

fecalis,

Parviromonas

Micra,

Porphyromonas

Gingivalis

and

Staphylococcus Aureus. The only bacteria present with a significant Z-score and a
statistically significant P score was the Candida Species.

Table 13. Results of Wilcoxon sign-rank test
Microorganisms

Z-test

Campylobacter rectus

Z = 0.000, P =NA

Candida species (yeast)

Z = 1.983, P = 0.047

Enteric gram negative rods

Z = 0.000, P = NA

Enterococcus faecalis

Z = -1.412, P = 0.157

Fusobacterium nucleatum

Z = 1.000, P = 0.317

Parvimonas micra (micros)

Z = 1.642, P = 0.100

Porphyromonas gingivalis

Z = 1.123, P = 0.261

Prevotella intermedia group
Staphylococcus aureus

Z = 0.000, P = NA
Z = -1.609, P = 0.107

Streptococcus constellatus

Z = 0.000, P = NA

Streptococcus intermedius

Z = -0.074, P = 0.940

Tannerella forsythia

Z = 0.074, P = 0.940

Microorganisms N(pre)

Z = 0.575, P = 0.565

Statistically significant difference compare to baseline (P<0.05))
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3.6 Suppuration
The suppuration on probing varied from positive suppuration to no suppuration. The two
categories are explained in the material and methods section. Each implants were probed
at six areas (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual and
disto-lingual). Each site was marked with an “N” for no suppuration and with an “S” for
suppuration. In the control group, twenty-seven sites had no suppuration and three sites
had a positive suppuration pre-operatively. At the post-operative appointment in the
control group, thirty sites had no suppuration. In the test group, thirty-nine sites had no
suppuration and nine sites had presence of suppuration pre-operatively. At the postoperative appointment in the test group, thirty-eight sites had no suppuration and ten sites
had presence of suppuration. Descriptive statistics are found in Table XX. Results from
the mixed, generalized linear model, showed no significant difference for the interaction
between time and group c2(3, N = 156) = 0.85, P = 0.838—Figure 5. Follow-up pairwise
comparisons with a Bonferroni adjustment found no significant differences between the
baseline suppuration for the test and control groups (Z146=0.25, P = 0.804). From pre-topost, we found no significant difference between the baseline and 6-month for either
groups (Control: Z76=0.35, P = 0.999, Treatment: Z76=0.38, P = 0.999). At 6-month, no
significant difference in suppuration between the groups was found (Z76=0.84, P =
0.999).

Table 14. Descriptive statistics for Suppuration
Baseline

6-Months

91

Group

N

S

N

S

Control

27 (90.0%)

3 (10.0%)

30 (100.0%)

0 (00.0%)

Test

39 (81.2%)

9 (12.5%)

38 (79.2%)

10 (20.8%)

Figure 19. Mean line plot of probability of a “0” (No suppuration) with 95% confidence
intervals

0: Probility of no suppuration , 1: Suppuration

3.7 Gingival Index
The gingival index varied from 0 to 3. The different categories are explained in the
material and methods section. In the control group, two implants had a gingival index of
1 and three implants had a gingival index of 2 pre-operatively. At the post-operative
appointment in the control group, one implant had a gingival index of 0, two implants
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had a gingival index of 1 and two implants had a gingival index of 2. In the test group,
four implants had a gingival index of 2 and four implants had a gingival index of 3 preoperatively. At the post-operative appointment in the test group, one implant had a
gingival index of 0, three implants had a gingival index of 1, two implants had a gingival
index of 2, and two implants had a gingival index of 3. These results are shown in Table
15. In control group, Score 0 increased by 20%. In test group Score 0 increased by
12.5% and Score 1 increased by 37.5%

Table 15. Descriptive statistics for Gingival Index
Pre-treatment
Group

Post-treatment

0

1

2

3

0

1

2

3

0

2

3

0

1

2

2

0

(00.0%)

(40.0%)

(60.0%)

(00.0%)

(20.0%)

(40.0%)

(40.0%)

(00.0%)

0

0

4

4

1

3

2

2

(00.0%)

(00.0%)

(50.0%)

(50.0%)

(12.5%)

(37.5%)

(25.0%)

(25.0%)

Control

Test

NOTE: Not enough data to conduct a statistical analysis

3.8 Plaque Index
The plaque index varied from 0 to 3. The different categories are explained in the
material and methods section. In the control group, three implants had a plaque index of 1
and two implants had a plaque index of 2 pre-operatively. At the post-operative
appointment in the control group, one implant had a plaque index of 0, two implants had
a plaque index of 1 and two implants had a gingival index of 3. In the test group preoperatively, two implant had a plaque index of 0, two implant had a plaque index of 1,
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one implants had a plaque index of 2, and three implants had a plaque index of 3. At the
post-operative appointment in the test group, three implants had a plaque index of 0, two
implants had a plaque index of 1, and three implants had a gingival index of 3. These
results are shown in Table 16.

Table 16. Descriptive statistics for Plaque Index
Pre-treatment
Score

Post-treatment

0

1

2

3

0

1

2

3

0

3

2

0

1

2

0

2

(00.0%)

(60.0%)

(40.0%)

(00.0%)

(20.0%)

(40.0%)

(00.0%)

(40.0%)

2

2

1

3

3

2

0

3

(25.0%)

(25.0%)

(12.5%)

(37.5%)

(37.5%)

(25.0%)

(25.0%)

(37.5%)

Control

Test

NOTE: Not enough data to conduct a statistical analysis

3.9 Reasons for implant loss
One implant was removed during a surgical procedure: implant #11 in the patient #10
who was in the test group. In the pre-operative radiograph, the implant lost from 25-50%
of bone mesially and distally which is the reason why we included the implant in the
protocol. However, during the procedure, we opened the flap and realized that the
implant had lost all the buccal bone and was mobile. That implant was therefore mobile
and had to be removed. We removed the implant, curetted the socket, irrigated and placed
a collaplug inside before suturing. That implant was not considered in our statistical
analysis.
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3.10

Intra-operative complications

With the exception of the implant that was removed (see section 3.9), there was no
complications during the surgical procedures.

3.11

Post-operative complications

Post-operative complications included pain and discomfort in patients #4 and #5, which
was controlled by pain medications. None of the patients developed an infection, an
allergic reaction, bleeding, an abscess, lost of the implant, etc.

3.12

Correlations

Using a Kendall’s rank correlation, we found positive correlations between smoking and
plaque Index (P < 0.001), prosthesis type and plaque index (P < 0.001), BOP and plaque
index (P < 0.001), BOP and prosthesis type (P < 0.001), prosthesis type and
microorganisms (P = 0.031), and smoking and microorganisms (P =0.002).
There was a negative correlation between bone fill and smoking (P=0.042). No
significant correlation was found between age and plaque index (P=0.682), bone fill and
plaque index (P=0.354), and BOP and microorganisms (P=0.911).

Table 17. Correlations
Variable

Variable

Correlati

Z

P-Value Comment

on
Smoking

Plaque

0.495

6.08

Index

P < More smoking more
0.001 plaque
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Prosthesis

Plaque

Type

Index

BOP

Plaque

0.588

7.94

0.001
0.340

4.68

Index
Age

Plaque

Prosthesis

-0.256

-0.40

Smoking

P = No significant
0.682 relationship

0.281

3.50

Type
Bone Fill

P < BOP more plaque
0.001

Index
BOP

P < Hybrid more plaque

P < Hybrid more BOP
0.001

0.256

2.03

P = More smoking less
0.042 bone fill

Bone Fill

Plaque

-0.107

-0.92

Index
BOP

Microorga

0.354 relationship
-0.009

-0.11

nisms
Prosthesis

Microorga

Type

nisms

Smoking

Microorga

P = No significant

P = No significant
0.911 relationship

0.442

2.14

P = Hybrid more bacteria
0.031

0.243

3.03

nisms

P = More smoking more
0.002 bacteria

Figure 19. Bone Fill per subject
The figure 19 reflects the bone fill for each individual subjects related to the mesial or
distal sites. The patient number four is the patient who has a negative bone fill which
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means this patient lost bone at the post-operative appointment at six months compared to
the pre-operative measurements. The table 17 shows the means and medians for each
subject in relation to their bone fill.

Table 18. Bone fill at 6-month per subject with means and medians in mm
Subject

Mean

Median

Min

Max

Control Group
1

2.68

2.68

1.93

3.44

2

1.34

1.34

1.13

1.56

3

0.96

0.96

0.13

1.78

4

-1.16

-1.16

-1.34

-0.97

Test Group
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5

0.72

0.72

-0.01

1.44

6

0.40

0.40

0.16

0.65

7

2.42

2.42

2.34

2.49

8

0.49

0.68

-0.22

0.83

9

2.48

2.48

1.66

3.29

10

0.46

0.28

-0.50

1.55
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4. DISCUSSION

In this clinical human study, 6-months clinical, radiographic and microbiological results
were compared with baseline data. The test group showed a significant decrease in
probing depth (P = 0.022) and clinical attachment level (P = 0.034) in 6 months,
however; the control group did not show a significant decrease (P = 0.850, P = 0.928,
respectively). The test group showed no significant increase in recession (P = 0.999). In
contrast, the control group did show a significant increase (P < 0.001). There was a
significant decrease in bleeding on probing in both groups at six months (P = 0.004). The
test group showed a significant bone fill (P = 0.021), however, the control group did not
show a significant change (P = 0.112). Before the procedure, the bacteria present
included Campylobacter rectus, Enteric gram negative rods, Fusobacterium nucleatum,
Prevotella intermedia, Parviromonas micras, Staphylococcus intermedius, Streptococcus
constellatus, Streptococcus intermedius, Prevotella intermedia. After the procedure, the
bacteria present included the same group of bacteria except Staphylococcus aureus,
which was absent after 6 months.

In both groups, the bacterial load decreased

postoperatively. Smoking, accumulation of plaque, hybrid prosthesis and enteric gramnegative rods were parameters found to have negative effect on treatment outcomes of
peri-implantitis.

4.1 Significance of this research
Various modalities have been described to treat peri-implant diseases. The primary goal
is to clean and disinfect the implant surface to make it biocompatible. This reduces
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inflammation and even allows re-osseointegration (6). Indeed, the preparation of the
surface and the resistance to corrosion may have an impact on the reaction of surrounding
tissues. Re-osseointegration has been defined as “the formation of new bone onto an
implant surface that was previously contaminated by a bacterial biofilm.” (9) An
important factor to consider is to re-establish the titanium oxide surface on the implants.
The titanium oxidation constitutes one of the principal reasons for implant
biocompatibility (Mouyhi 2000 (53)).

Although CO2 lasers do not influence osteoblast attachment, it has been reported to be
safe on the tissue and can increase bone regeneration when used for decontamination of
implants in the treatment of peri-implantitis. Used with appropriate settings, there is no
risk in damaging the adjacent tissues and it allows proliferation of fibroblasts (6). Also,
the overproduction of H2O2 allows for the thickening of the titanium oxide layer on the
implant surface. This may therefore permit the incorporation of calcium ions and
phosphorus into the osseous matrix (10). The incidence of peri-implantitis is increasing
every year and it is important to have a predictable treatment strategy. To this day, there
is no predictable treatment to use around implants affected by this disease. If a
predictable treatment could be proposed, the impact could be significant for dentists and
patients so they don’t need to go through several surgeries to replace failing implants in
order to regain function and esthetics. In a recent study published in 2015 by Froum et al.
(43A), reported 98.5% success rate for an average of 4 years in the treatment of periimplantitis.
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4.2 Comparisons of the two treatment protocols
The two treatment protocols lead to similar clinical, microbiological and radiographic
outcomes. According to our clinical results; the probing depth, clinical attachment levels,
recession, bleeding on probing, suppuration, gingival indices and plaque indices were
statistically significantly better in the test group post-operatively but there were no
statistical significant differences between the protocols pre-operatively and postoperatively (see Tables 3, 4, 5, 6). There was a higher increase in clinical attachment gain
in the test group compare to the control group (See Table 7). This was due principally to
patient’s numbers seven and nine that had a significant increase in clinical attachment
levels at the six months follow-up. In the radiographic bone fill results; the test group also
yielded better results individually but without any statistical significant difference
between groups. This was due in part to patient’s numbers seven and nine but also patient
number four in the control group who had a negative bone fill which translate to a bone
loss at six months post-op. There were no statistical differences in the microbiological
results pre- and post-operatively between both groups but both groups had a decrease in
the bacterial load from pre- to post-operative. There was an increase in the enteric grannegative rods in the control group due to one patient (patient number four) but this was
not statistically different. The lack of significant results in the analysis from pre- to postbetween groups could be due to the small number of patients included (10), which may
have led the quantitative analysis to be underpowered.

4.3 Correlations
4.3.1 Association of peri-implantitis and smoking
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In our study, smokers in both groups were associated with more bone loss and
consequently less bone fill after the procedure. In the study from Roos-Jansaker and
Renvert 2006 (25), smokers had an odds ratio of 2.9 of having peri-implantitis compare
to non-smokers (p= 0.009). In an implant-based meta-analysis, Sgolastra et al. in (2014)
(104) revealed a higher and statistically significant risk of peri-implantitis in smokers
(OR: 2.1, 95% CI: 1.34–3.29, P = 0.001) compared with nonsmokers. Indeed in this
study, they comprised seven papers, which included risk ratio from 1.88 to 4.14 for
cigarettes smokers.
Swierkot et al. in 2012 (105) published a univariate analysis demonstrating a significantly
higher risk for peri-implantitis in implants in smokers (OR = 3.02 and 2.87 with P =
0.009 and 0.038, respectively). They indicated that the odds ratio for a current smoker
was 3.0 and the odds ration for a former smoker was 2.5. Another study, which has
described the influence of tobacco smoking, is a meta-analysis by Strietzel et al. in 2007
(106). This study indicated significant risks of implant complications for smokers
compared to non-smokers. The meta-analysis included thirteen papers and eleven of
those concluded that there was significantly more radiographic bone loss in smokers.
Two of those studies were also investigating the effect of smoking on implants
undergoing peri-implantitis treatments and concluded less bone fill with smokers (106).
A study by Schwartz-Arad (2002) (107) included 261 patients (172 non-smokers and 89
smokers) and 959 implants. They found a significant (P< 0.05) incidence of
complications in the smoking group and this became more significant (P<0.04) when the
patients smoked more cigarettes and for a longer period of time.
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In this present study, there was a significant difference in smokers and non-smokers
considering the bone fill after the six-months post-op appointment (P = 0.042). Smokers
had 2.40 times lower levels of bone fill compare to non-smokers.
Fransson et al. in 2008 (108) demonstrated a residual probing depth of ≥ 6mm in 40% of
smokers after surgical treatment of peri-implantitis and only 20% of the implants in nonsmokers had ≥ 6mm probing depth.
The present study shows that 42% of the smokers had residual probing depth of ≥ 6mm
and only 13% of the non-smokers had ≥ 6mm probing depth. Thus, tobacco consumption
seems to have a negative impact on healing and regenerative outcomes (See Table 3).

4.3.2 Association of peri-implantitis and plaque
In a publication by Canullo et al. in 2015 (110), they discussed how important plaque
control is and how it influences the risk for peri-implant diseases. They had 53 patients
and 113 implants in the peri-implantitis group and registered their modified plaque score.
They had one patient with a plaque score of 0, 49 implants had an index of 1, 39 implants
had an index of 2 and 24 implants had an index of 3. The mean plaque levels were 1.7 for
all implant samples. Canullo (110) also mentioned that the plaque index in his study was
positively related to bone loss. In Canullo study, the plaque index was 0.84 preoperatively and 0.70 post-operatively.
In the present study, after 6 months, the implants with a plaque index of 0 and 1 had a
mean radiographic bone fill of 1.34mm and the implants with a plaque index of 2 or 3
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had a mean radiographic bone fill of -0.375mm. This was not statistically significant and
could be due in part by the small sample size of this research (See Table 17).
In another study published in 2016 by Papathanasiou et al. (109), plaque accumulation
was the most prevalent etiologic factor with 91.1% of implants with plaque associated
with peri-implantitis. In our study, 84% of implants had plaque pre-operatively and 69%
of implants had plaque post-operatively.
Koldsland et al. 2011 published an article on risk factors for peri-implantitis. Amongst
the main ones included previous periodontal diseases of untreated periodontal diseases
and smoking. Plaque at implant site was associated to increase of inflammation but not to
peri-implantitis like in this study.
Numerous articles include the accumulation of plaque as a risk factor for peri-implantitis
and healing after treatment (Serino et al. 2009 (116) and Ferreira et al. 2006 (31)) related
to poor oral hygiene.

4.3.3 Association of smoking and microorganisms
A study published in the Journal of Dental research by Tsigarida et al. in 2015 (111)
discussed the microbiomes associated to peri-implantitis for smokers and non-smokers.
In was discussed that smoking influences the microorganisms present even around
healthy implants (111). Indeed, there is an increase in pathogenic bacteria and a decrease
of commensal bacteria in smokers. Very few species changed from peri-implant
mucositis to peri-implantitis indicating a pathogen-rich state already established in
smokers. Seventy-nine species were more abundant in the smoker group including:
Lactobacillus, Prevotella, Treponema, Propionibacterium and Pseudomonas. Seventy-
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seven other species including Streptococcus, Selenomonas, and Porphyromonas were
elevated in non-smokers (111).
In our study, all patients who smoked cigarettes were associated with a higher level of
Fusobacterium Nucleatum and Parvirmonas Micra and also correlated with Prevotella
Intermedia and Tannerella forsythia. One patient also had Enteric Gram-Negative rods.
We weren’t able to culture any other species from them. The non-smokers had a more
diversify microbiome consisting of Streptococcus constellatus, Campylobacter rectus,
Staphylococcus aureus, Tannerella forsythia, Fusobacterium Nucleatum, Parvirmonas
Micra and Prevotella Intermedia. (See Table 17)
Like Tsigarida et al. (111) and Mason et al. (112), in our study, the microbiome of
smokers exhibited lower diversity and similar subgingival bacteria type.

4.3.4 Association of peri-implantitis and microorganisms
In our study, Fusobacterium nucleatum had the highest mean of cultivable
microorganisms pre-operatively. F. Nucleatum is a bridge between the commensal/early
species and the pathogenic/late species (Mason et al. 2014 (112)). The high abundance of
this bacterium in the present study around the implants affected with peri-implantitis at
the pre-operative microbiologic culturing suggests its importance in the development of
peri-implant diseases.
According to Swierkot et al. (105), the pathogenesis of peri-implantitis is related to the
microorganisms present principally spirochetes and gram-negative anaerobic bacteria
when prevailing in large quantities. They also mentioned that the immune response to this
load of bacteria plays a major role in the soft and hard tissue destruction around implants.
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In a study published by Consuegra et al. (113), Enteric gram negative rods were
associated to 36% of implants and 75% of these implants were refractory to surgical
treatment. In our study, Enteric gram negative rods were associated to 31% of implants
and 50% of these implants were refractory to surgical treatment. Those implants were in
the same two patients (numbers 4 and 10). Interestingly those 2 patients were the patients
restored with a hybrid prosthesis.
In a study by Canullo et al. (110), the bacteria found around implants affected by periimplantitis were mostly in the orange complex species from Socransky et al (114). These
bacteria including F. Nucleatum, P. Micros, and P. Intermedia were mostly found at the
implant connection compared to the peri-implant sulcus.
In the present study, we only took microbiological samples of the implant sulcus and
therefore cannot identify the bacteria present in the implant connection. The bacteria
around the peri-implant sulcus of the included implants that are from the orange complex
included: Campylobacter rectus Fusobacterium Nucleatum, Parvirmonas Micra and
Prevotella Intermedia (See Table 12).

4.3.5 Association of plaque and prosthesis type
In our study, plaque was statistically related to the prosthesis type (P < 0.001), meaning
there was more plaque with a hybrid prosthesis than with a single unit crown on implant.
This could be due to the difficulty of cleaning under the prosthesis with the hybrid
design. Indeed, hybrids have flanges on the buccal to mimic the buccal gingiva in order
to hide the metal of the multi unit abutment components and to be more esthetic.
Abi Nader et al. 2015 (115), did a study on hybrid prosthesis and peri-implantitis and
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concluded that plaque accumulation around implants was 41.3 % and also that implants
placed close together had more plaque accumulation which is sometimes the case with
hybrid prosthesis with more than four implants.
In the present study, implants with peri-implantitis associated to hybrids had four times
more plaque accumulation than implants with peri-implantitis associated to a single unit
crown. This was statistically significant (P<0.001) (See Table 17).
In a study by Decks et al. (27), patients that had four or more implants placed in one arch
had a odd ratio of 15.09 of developing peri-implantitis compare to 1 for less than four
implants (P<0.001).

4.3.6 Association of smoking and plaque index
Smoking has been reported to increase the rate of plaque accumulation compare to nonsmokers. In a study by MacGregor et al. (117), they described that is was not the weight
of the plaque that was higher but the concentration of the calcium/phosphorus ratio
(P<0.05). Since the phosphorus ions were not increased, they suspected the tobacco
intake to increase the levels of the calcium ions by increasing the saliva flow.
In the same study (117) it was found that smokers had higher and faster plaque
accumulation during a five-day period. Although there was a positive relation between
the amounts of plaque and the intake of tobacco, this was not statistically significant.
In our study, the plaque index was correlated with smoking, with a correlation of 0.495
and a P value of less than 0.001, which was statistically significant (See Table 18). The
modified plaque index was either 2 or 3 for the smokers pre-operatively, which makes the
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healing process more complicated when combined with smoking and increases the risk
for failure.

4.3.7 Association of bleeding on probing with microorganisms
In a study by Canullo et al. (110), they observed a positive correlation between bleeding
on probing and the presence of Porphyromonas Gingivalis and Tannerella Forsythia on
implants.
This fact was also confirmed with Mombelli and Décaillet (119) in a meta-analysis
published in 2011, which stipulated more inflammation and increased probing depth with
gram-negative bacteria. They reported several species responsible for the increase in
inflammation including F. Nucleatum and P. Intermedia.
This study demonstrated a high incidence of bleeding on probing pre-operatively. Indeed,
there was 90.0% and 87.5% of bleeding on probing in the Control and Test group
respectively (see Table 9). Post-operatively, the bleeding on probing decrease to 66.7%
and 60.4% in the Control and Test groups, respectively (see Table 9 and Figure 16).
There is also a decrease in most of the microorganisms, even totally eradiating
Staphylococcus Aureus post-operatively. Even though, we see a tendency with a decrease
bleeding on probing and the bacteria present, the association between bleeding on
probing and the microorganisms present was not statistically significant (See Table 18).
This may be due to the small sample size. Larger sample size may reach to a statistically
significant level.
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This clinical controlled human study shows promising clinical, microbiological and
radiographic results for the treatment of peri-implantitis using CO2 laser combined with
hydrogen peroxide as a new treatment strategy. Further longitudinal studies with larger
sample size are needed to confirm these results.

4.4 Conclusions and future research

This clinical randomized human study enabled us to discover interesting results.
To the best of our knowledge, this is the first study that tests the potential of CO2 laser
and H2O2 and a regenerative procedure around implants in-vivo. It is also the first time
that it is compared to a control group without the involvement of the laser. This study
also involves the analysis of the results clinically, microbiologically as well as
radiographically.
In summary, in this clinical human study, 6-months clinical, radiographic and
microbiological results were compared with baseline data. The test group including CO2
laser combined with H2O2 showed a significant decrease in probing depth (P = 0.022) and
clinical attachment level (P = 0.034) in 6 months, however; the control group did not
show a significant decrease (P = 0.850, P = 0.928, respectively). The test group showed
no significant increase in recession (P = 0.999), in contrast, the control group did show a
significant increase (P < 0.001). There was a significant decrease in bleeding on probing
in both groups at six months (P = 0.004). The test group showed a significant bone fill (P
= 0.021), however, the control group did not show a significant change (P = 0.112).
Before the procedure, the bacteria present included Campylobacter rectus, Enteric gram
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negative rods, Fusobacterium nucleatum, Prevotella intermedia, Parviromonas micras,
Staphylococcus intermedius, Streptococcus constellatus, Streptococcus intermedius,
Prevotella intermedia. After the procedure, the bacteria present included the same group
of bacteria except Staphylococcus aureus, which was absent after 6 months.

In both

groups, the bacterial load decreased postoperatively. Smoking, accumulation of plaque,
hybrid prosthesis and enteric gram-negative rods were parameters found to have negative
effect on treatment outcomes of peri-implantitis.
Our conclusions for this study are as following:
1. In this study, smokers had a statistically significant less bone fill after the sixmonths post-op appointment (P = 0.042). Smokers had 2.40 times lower levels of
bone fill compare to non-smokers. Furthermore, the smokers had residual probing
depth of ≥ 6mm and only 13% of the non-smokers had ≥ 6mm probing depth.
Thus, tobacco consumption seems to have a negative impact on healing and
regenerative outcomes and smoking is a risk factor for peri-implantitis.

2. In our study, all patients who smoked cigarettes were associated with a higher
level of Fusobacterium Nucleatum and Parvirmonas Micra and also linked with
Prevotella Intermedia and Tannerella forsythia. One patient also had Enteric
Gram-Negative rods. The non-smokers had a more diverse microbiome consisting
of Streptococcus constellatus, Campylobacter rectus, Staphylococcus aureus,
Tannerella forsythia, Fusobacterium Nucleatum, Parvirmonas Micra and
Prevotella Intermedia.
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3.

Most of the bacteria harboured around the implants affected by peri-implantitis
were

from

the

orange

complex

and

included:

Campylobacter rectus

Fusobacterium Nucleatum, Parvirmonas Micra and Prevotella Intermedia.
Removal of plaque and bacteria is imperative in order to have peri-implant health.

4. In the present study, plaque was statistically positively correlated to the prosthesis
type (P < 0.001), meaning there was more plaque with hybrid prosthesis than with
a single unit crown on implant. The flanges on the buccal of the prosthesis make
the flossing and the brushing around the implants difficult. Hybrid prosthesis have
a higher prevalence of peri-implantitis.

5. Clinical, microbiological and radiographic improvements were noted in both
groups post-operatively. The test group showed a tendency for higher increase in
clinical attachment level gain and decrease in probing depth while not increasing
recession. Both groups showed better BOP scores after treatment.

6. Radiographic bone fill wasn’t successful in all patients. Some patients were
refractory to the surgical procedure. These patients had similar characteristics
including smoking tobacco, presence of Enteric gram negative rods and 50% of
bone loss pre-operatively.

7. The treatment of peri-implantitis must include a surgical procedure. It is necessary
for the proper access to the implant and visualization of the defect to open a flap.
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Within the limitations of this study there is a relatively high occurrence of peri-implant
diseases that can manifest and persist for years. Long-term maintenance care for high-risk
groups is essential to reduce the risk of peri-implantitis. Informed consent for patients
receiving implant treatment must include the need for such maintenance therapy. This
clinical controlled human study shows promising clinical, microbiological and
radiographic results for the treatment of peri-implantitis using CO2 laser combined with
hydrogen peroxide as a new treatment strategy. Further longitudinal studies with larger
sample size are needed to confirm these results.
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APPENDIX C
Figures of the procedure in the Control Group
Patient #1 (implant #4)
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Figures 20 and 21. Pre-operative pictures
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Figure 22. Removal of prosthesis
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Figures 23 and 24. Reflection of the flap and exposure of the defect
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Figure 25. Allograft placement and dermis placement, secured with chromic gut sutures
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Figures 26 and 27. Flap closure and prosthesis placed back
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Figures 28 and 29. One-week post-operative
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Figure 30 and 31. One-month post-operative
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Figures 32 and 33. Six months post-operative
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APPENDIX D
Figures of the procedure in the Test Group
Patient #7 (implant #14)
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Figures 34 and 35. Pre-operative pictures
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Figures 36 and 37. Reflection of the flap and exposure of the defect
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Figures 38. Pictures of the settings used with the CO2 laser
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Figures 39. Allograft bone placement in the defect
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Figure 40. Flaps closed with primary intention and prosthesis placed back
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Figures 41 and 42. One-week post-operative
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Figures 43 and 44. One-month post-operative
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Figures 45 and 46. Six months post-operative
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APPENDIX E
Digital radiographs of the procedure in the Control Group
Patient #1 (implant #4)
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Figure 47. Pre-operative digital radiographs (Bitewing)
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Figure 48. Pre-operative digital radiograph (periapical)
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Figure 49. Post-operative digital radiographs (bitewing)
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Figure 50. Post-operative digital radiograph (periapical)
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APPENDIX F
Digital radiographs of the procedure in the Test Group
Patient #7
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Figure 51. Pre-operative digital radiograph (bitewing)
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Figure 52. Pre-operative digital radiograph (periapical)
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Figure 53. Post-operative digital radiograph (Bitewing)
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Figure 54. Post-operative digital radiograph (periapical)
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